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Mycobacteria constitute a heterologous genus comprising highly pathogenic species 
like the members of the Mycobacterium tuberculosis-complex as well as less pathogenic or 
opportunistic species like Mycobacterium fortuitum or Mycobacterium smegmatis. Many 
species of the genus are of particular medical importance because they cause severe diseases. 
In general mycobacteria are distinguished by their growth rates between fast- and slow-
growers. 
 
1.1 Mycobacteria are distinguished by their growth characteristics 
It is eye-catching that the highly pathogenic Mycobacterium species like members of 
the M. tuberculosis-complex, Mycobacterium leprae or Mycobacterium avium belong to the 
slow-growing mycobacteria with generation times of more than 5 hours, whereas many 
apathogenic or opportunistic Mycobacterium species like for example M. peregrinum, M. 
smegmatis or M. fortuitum belong to the rapidly growing mycobacteria (RGM) having 
generation times of less than 5 hours (Table 1). M. tuberculosis, for example, has a generation 
time of 14 – 15 hours under optimal conditions ( 1999). It is unknown, if and in which way 
the differences in their growth rates may contribute to the virulence and intracellular 
persistence of the different Mycobacterium species. 
 
Table 1: Classification of mycobacteria associated with their growth characteristics. *: Members of the M. 
tuberculosis-complex. 
Species Risk group Growth Intracellular persistence 
M. tuberculosis * 3 slow-growing + 
M. africanum * 3 slow-growing + 
M. bovis * 3 slow-growing + 
M. leprae 3 non-cultivable + 
M. ulcerans 3 slow-growing + 
M. avium 2 slow-growing + 
M. intracellulare 2 slow-growing + 
M. chelonae 2 fast-growing ? 
M. fortuitum 2 fast-growing + 
M. smegmatis 2 fast-growing - 
M. peregrinum 1 fast-growing - 




Several hypotheses are discussed as possible reasons for the different growth rates of 
slow- and fast-growing mycobacteria. Hiriyanna et al. ( 1986) found the DNA elongation rate 
in M. tuberculosis to be eleven times slower than in M. smegmatis. Similarly, the RNA 
elongation rate of M. tuberculosis was shown to be ten times slower compared with 
Escherichia coli (Harshey & Ramakrishnan, 1977). Another hypothesis assumed that the 
amount of rRNA molecules influences the growth rates. While slow-growing mycobacteria 
often only possess one rRNA operon, RGM usually have two rRNA operons and/or strong 
promoters in front of their rRNA operons (Bashyam et al., 1996; Bercovier et al., 1986; 
Gonzalez-y-Merchand et al., 1996; Gonzalez-y-Merchand et al., 1997; Gonzalez-y-Merchand 
et al., 1998; Ji et al., 1994b; Ji et al., 1994a; Verma et al., 1999). The DNA-binding protein 
MDP1 (mycobacterial DNA-binding protein 1) identified in M. bovis BCG (Matsumoto et al., 
1999) was also assumed to slow down growth (Furugen et al., 2001; Matsumoto et al., 2000). 
An important characteristic biological property of mycobacteria probably influencing the 
growth characteristics is their thick hydrophobic cell wall (Jarlier & Nikaido, 1990). The 
present model of the mycobacterial cell wall (Figure 1) includes the presence of an outer 
membrane (OM). The OM is composed of long fatty acids, the mycolic acids (up to 90 carbon 
atoms), and non-covalently bound lipids, which complement the ordered arrangement of 
mycolic acids to an asymmetric bilayer (Niederweis, 2003). 
 
 
Figure 1: Structural model of the mycobacterial cell wall. The asymmetric OM is composed of lipids and 
mycolic acids, which are covalently bound to the arabinogalactan-peptidoglycan co-polymer. The OM is 
penetrated by porins mediating the uptake of hydrophilic substances across the membrane. (Abbreviations: AG: 




Because of the length of mycolic acids, the mycobacterial OM is the thickest known 
biological membrane with a very low fluidity. Brennan and Nikaido ( 1995) proposed the 
mycobacterial OM to be an efficient permeability barrier protecting the bacilli from toxic 
compounds. It is also thought to be the main determinant of mycobacterial resistance to most 
common antibiotics or chemotherapeutic agents. Diffusion of small hydrophilic nutrients 
across this extraordinary hydrophobic barrier is mediated by porins penetrating the cell wall. 
 
1.2 The extremely hydrophobic mycobacterial OM is penetrated by porins 
Niederweis et al. ( 1999) identified a new type of porin (MspA) in M. smegmatis and 
indicated that homologous genes seem to be present in RGM, but apparently absent in slow-
growers (Niederweis et al., 1999). MspA is an extremely stable octameric protein composed 
of 20 kDa monomers (Faller et al., 2004; Heinz et al., 2003a). It has a selectivity for cations 
and the single channel conductance amounts to 4.6 nS (Niederweis et al., 1999). Besides the 
mspA gene, M. smegmatis possesses three homologous genes named mspB, mspC, and mspD. 
The main diffusion pathway of M. smegmatis is provided by MspA (Engelhardt et al., 2002; 
Stahl et al., 2001). A mutant strain with a deletion of mspA exhibited a 9 fold reduced 
permeability for cephaloridine and a 4 fold reduced permeability for glucose. However, the 
growth rate of the mspA deletion mutant in minimal medium with glucose as carbon source 
did not differ from the growth rate of the wild type (Stahl et al., 2001). Lichtinger et al. ( 
1999) detected in detergent extracts of M. bovis BCG a porin that produced channels with a 
conductance of 0.8 nS with selectivity for anions and another channel of 4 nS. In accordance 
with these experiments, two other research groups demonstrated the existence of channels in 
the cell wall of the closely related species M. tuberculosis. Kartmann et al. ( 1999) described 
two porins in M. tuberculosis. One of them is composed of 15 kDa subunits and has a channel 
conductance of 0.7 nS. The other porin is a 60 kDa  protein with a conductance of 3 nS. Based 
on nucleic acid sequence homology, Senaratne et al. ( 1998) identified the channel protein 
OmpATb from M. tuberculosis. OmpATb has a MW of 38 kDa, a pore diameter of 1.4 to 1.8 
nm and a single channel conductance of only 0.7 nS. An ompATb deletion mutant was shown 
to be impaired in growth at low pH and in the ability to grow in macrophages (Raynaud et al., 
2002). However, in general the amount of protein was too low to allow a characterization of 
proteins. Porins of members of the M. tuberculosis-complex are of particular interest because 




the porin pathway would promote the design of new drugs to fight tuberculosis (Niederweis, 
2003).  
Porins not only facilitate the diffusion of small hydrophilic molecules into the cell, but 
can also be involved in various stages of the infection process. For example, porins can 
function as binding sites of components of the complement cascade; and as adhesin they can 
fortify invasiveness. Porins can influence apoptosis, inhibit phagocyte function and induce 
cytokine expression (Achouak et al., 2001; Galdiero et al., 2003).  Porins from Neisseria, for 
example, are involved in multiple functions during the infection process. They can activate B 
cells and other antigen-presenting cells thereby acting as adjuvants. Their effect on the 
immune response is mediated by upregulation of the costimulatory molecule B7-2 on the 
surface of antigen-presenting cells. Neisserial porins can also interact with components of the 
complement cascade and by co-localization with mitochondria modulate apoptosis (Massari et 
al., 2003).  
 
1.3 Many slow-growing mycobacteria cause severe diseases 
Various slow-growing mycobacteria are capable to cause serious diseases. For 
example M. leprae, the causative agent of leprosy, is despite decreasing global prevalence still 
endemic in countries such as India, Vietnam or the Philippines. Leprosy is a transmissible 
infectious disease, which leads to skin lesions and peripheral nerve enlargement and 
impairment (Boggild et al., 2004). But the most common pathogen among the genus is M. 
tuberculosis, the causative agent of human tuberculosis, which causes latent and acute illness. 
Tuberculosis is regarded as re-emerging disease causing more than 1.5 million deaths per 
year. Every second someone in the world is newly infected with M. tuberculosis and one third 
of the world’s population is latently infected and is at risk to develop active tuberculosis 
during the lifetime. M. tuberculosis world-wide kills more people than any other bacterial 
pathogen (www.who.int/topics/tuberculosis/en/). Owing to the persistence of M. tuberculosis 
in infected individuals and the increasing frequency of antibiotic resistant strains, treatment of 
tuberculosis requires medication with a combination of different antibiotics (first line 
tuberculosis drugs: rifampin, isoniazid, pyrazinamide and ethambutol) during at least six 
months. In many countries, such a long and expensive therapy cannot reliably be 
administered. The only vaccine available, the attenuated M. bovis derivative BCG (Bacillus 




The most frequent disease pattern caused by M. tuberculosis is a disease of lungs. 
Inhaled droplets containing a few number of bacilli are engulfed by alveolar macrophages and 
through interaction of mycobacterial components with Toll-Like receptors (TLR) the 
macrophages produce cytokines and chemokines that serve as signals of infection. The signals 
result in migration of monocyte-derived macrophages and dendritic cells to the site of 
infection in the lungs. Dendritic cells containing mycobacteria migrate to the local lymph 
nodes and recruit CD4+ and CD8+ T cells, which are primed against mycobacterial antigens. 
These T cells expand and migrate back to the lungs (the origin of infection). The migration of 
macrophages, T cells and B cells to the site of infection results in formation of a granuloma, a 
characteristic element of tuberculosis. Also dendritic cells, endothelial cells and fibroblasts 
participate in formation of a granuloma. Mycobacteria remain in this restricted environment 
but are not eradicated and the host is latently infected. (Tufariello et al., 2003). Although M. 
tuberculosis persists intracellularly in the early phagosomal compartment by inhibiting the 
phagolysosome fusion, activated macrophages, which produce reactive oxygen and nitrogen 
intermediates, are able to kill a part of the bacteria or prevent them from replication. Due to 
the infection with M. tuberculosis, different T cell populations (T helper 1) produce interferon 
γ (IFN-γ), which is the major mediator of macrophage activation beside tumor necrosis factor 
α (TNFα) (Kaufmann, 2002). While the molecular components and pathways of the host 
immune response are well studied, the mechanisms of persistence of M. tuberculosis, such as 
dormancy and persistence remain barely investigated. 
 
1.4 Pathogenic rapidly growing mycobacteria 
The species of rapidly growing mycobacteria (RGM) able to cause human disease 
belong basically to the M. fortuitum-group, the Mycobacterium chelonae/abscessus-group and 
the M. smegmatis-group. Members of these groups are commonly seen in municipal tap water 
and health care associated outbreaks are often associated with contact to tap water or water 
sources such as ice (Brown-Elliott & Wallace, 2002).  
The M. fortuitum-group includes three taxa: M. fortuitum, M. peregrinum and a third 
biovariant complex. The M. fortuitum-group is involved in 60% of localized cutaneous 
infections in immunocompetent persons caused by RGM but is a rare cause of pulmonary 
disease. Most or all of the cases of community-acquired or health care-associated diseases 




lesions, wound infections, postinjection abscesses, postsurgical wound infections or 
pulmonary disease in previously healthy hosts. Little is known about the virulence 
mechanisms and persistence of this human pathogen. However Cirillo et al. ( 1997) showed 
M. fortuitum to be capable to replicate in amoebae. Unlike M. fortuitum, there is no published 
review evaluating the clinical significance of M. peregrinum (Brown-Elliott & Wallace, 
2002).  
The most common member of the M. smegmatis-group is M. smegmatis, a saprophytic 
species, which occasionally is capable to cause skin and soft tissue lesions. It has been 
reported to be involved in cellulitis, localized abscesses and osteomyelitis of wound sites 
following traumatic events. Furthermore, health care-associated diseases, for example, 
catheter sepsis, infected pacemaker sites and sternal wound infections can be caused by M. 
smegmatis (Brown-Elliott & Wallace, 2002). Lung infections caused by M. smegmatis occur 
rarely (Daley & Griffith, 2002; Howard & Byrd, 2000; Kumar et al., 1995; Schreiber et al., 
2001; Vonmoos et al., 1986). However, M. smegmatis has been identified as causative agent 
of fatal disseminated disease in patients with IFN-γ receptor deficiencies (Andrews & 
Sullivan, 2003; Howard & Byrd, 2000; Jouanguy et al., 1999; Pierre-Audigier et al., 1997). 
These patients are often heavily affected by otherwise poorly pathogenic mycobacteria, since 
the ability to respond to IFN-γ is of crucial importance for the destruction of intracellular 
pathogens. The ability of M. smegmatis to cause severe disease in patients not responding 
properly to IFN-γ gave rise to investigate the factors influencing its intracellular persistence. 
M. smegmatis is generally considered to be an environmental saprophytic bacterium. Unlike 
the typical intracellularly growing bacteria of the M. tuberculosis-complex, M. smegmatis is 
not able to inhibit the acidification of the phagosome (Kuehnel et al., 2001). Nevertheless, M. 
smegmatis has some capacity to persist intracellularly in mononuclear phagocytes and has 
been reported to grow during the first day after infection and to be partly eliminated during 
the second day (Lagier et al., 1998). 
 
1.5 Environmental persistence of mycobacteria 
Another interesting feature of some mycobacterial species is their ability to survive 
inside amoebae, classifying mycobacteria as “amoeba-resistant microorganisms” (Greub & 
Raoult, 2004). The mechanisms used by macrophages and amoebae for phagocytosis, 




Dawidowicz, 1990a; Allen & Dawidowicz, 1990b; Brown & Barker, 1999; Greub & Raoult, 
2004; Winiecka-Krusnell & Linder, 2001). Reciprocally, the strategies employed by bacteria 
to escape destruction by macrophages or amoebae are also similar. M. avium, for example, 
survives in macrophages by inhibiting lysosomal fusion and the same survival strategy is used 
in amoebae (Brown & Barker, 1999; Cirillo et al., 1997; Steinert et al., 1998). The parallels 
between the interaction of bacteria with macrophages and with amoebae are best studied for 
Legionella pneumophila. The pmi genes (protozoan and macrophage infection) of L. 
pneumophila are required for survival both in macrophages and in amoebae. Additionally, L. 
pneumophila possesses the mil genes (macrophage-specific infectivity loci), which are 
essential only for survival in macrophages (Kwaik Y.A et al., 1998). This supports the theory 
that an evolutionary selection for survival in environmental protozoa has enabled intracellular 
pathogenic bacteria to develop the capacities necessary for survival in macrophages (Brown 
& Barker, 1999; Steinert et al., 1998; Winiecka-Krusnell & Linder, 2001). In this context, it is 
interesting that passage through amoebae can enhance the virulence of pathogenic 
intracellular bacteria. As shown by Cirillo et al. ( 1997), growth of M. avium in amoebae 
enhances entry into epithelial cells and intracellular replication. Amoeba-grown M. avium are 
also more virulent in the beige mouse model of infection. Cirillo et al. observed a correlation 
between the virulence of mycobacterial species and survival in amoebae. This correlation was 
also reported by other authors (Neumeister, 2004; Pozos & Ramakrishan, 2004; Strahl et al., 
2001) and supports the proposal to use amoebae, in addition to cell lines and animals, as 
model systems to study persistence. 
 
1.6 Goals of this study 
Mycobacteria differ not only by their various growth rates but also the ability to persist 
intracellularly. Whereas members of the M. tuberculosis-complex are known to persist 
intracellularly within macrophages (Taylor et al., 2003) and protozoa (Deretic & Fratti, 1999), 
M. smegmatis was shown to be killed by human monocytes and A. castellanii (Barker et al., 
1996; Cirillo et al., 1997). As mentioned above, it is evident that a major difference between 
fast- and slow-growing mycobacteria lies in their equipment with porins (Niederweis, 2003). 
This work will address the question, how the diverse equipment of mycobacteria with porins 




The aim of the first part of this study was to express the mspA gene from M. 
smegmatis in M. bovis BCG and to analyze the effects of its expression on growth 
characteristics and intracellular persistence of M. bovis BCG.  
To address the question if porins from RGM like M. smegmatis have the potential to 
influence the infection process, two porin mutants from M. smegmatis were used and their 
extracellular and intracellular growth was analyzed. In the first mutant mspA was deleted 
(Stahl et al., 2001), while in the second mutant mspA and mspC were deleted (Stephan et al., 
2004). Intracellular persistence of the mutants compared to the parental strain was analyzed in 
different phagocytic cells including amoebae. For a better understanding of the impact of 
mycobacterial porins on virulence, porins from members of the M. fortuitum-group, which 




Materials and Methods 9 
2 Materials and Methods 
2.1 Strains and growth conditions 
All mycobacterial strains (Table 2) were grown in Middlebrook 7H9 medium (BD 
Biosciences, Heidelberg, Germany) supplemented with ADC (BD Biosciences) and 0.05% 
Tween 80 at 37°C (except of M. peregrinum strains, which were grown at 30°C) without 
shaking or on Middlebrook 7H10 agar (BD Biosciences) supplemented with OADC (BD 
Biosciences), respectively. Media were supplemented when required with 25 µg ml-1 
kanamycin or 75 µg ml-1 hygromycin B for selection of recombinant mycobacteria. E. coli 
DH5α was grown in LB medium at 37°C (Sambrook et al., 1989). Media were supplemented 
with 100 µg ml-1 kanamycin or 200 µg ml-1 hygromycin B for selection of recombinant E. 
coli. 10 µg ml-1 tertracycline was added for selection of transposon mutants of E. coli DH5α. 
 
Table 2:  Mycobacterial strains used in this work. 
Strains Characteristics Reference 
M. bovis BCG (Copenhagen) 
M. bovis BCG (pMV306) 
M. bovis BCG (pSSa100) 
M. smegmatis mc2155 
M. smegmatis SMR5 
M. smegmatis MN01 
M. smegmatis MN01 (pMN013) 
M. smegmatis MN01 (pSSa100) 
M. smegmatis ML10 
M. smegmatis ML10 (pMN013) 
M. smegmatis ML10 (pSSa100) 
M. fortuitum DSM 46621 
M. fortuitum 10851/03 
M. fortuitum 10860/03 
M. peregrinum 9912/03 
M. peregrinum 9926/03 
Vaccine strain 
BCG derivative, harboring the plasmid pMV306, KMR 
BCG derivative, harboring the plasmid pSSa100, KMR 
Type strain 
M. smegmatis mc2155 derivative, SMR 
SMR5 derivative, ∆mspA 
MN01 derivative, harboring the plasmid pMN013, HYGR 
MN01 derivative, harboring the plasmid pSSa100, KMR 
SMR5 derivative, ∆mspA and ∆mspC 
ML10 derivative, harboring the plasmid pMN013, HYGR 
ML10 derivative, harboring the plasmid pSSa100, KMR 
Type strain; HYGR 
Human patient isolate, KMR 
Human patient isolate, KMR and HYGR 
Human patient isolate 





(Sander et al., 1995) 
(Stahl et al., 2001) 
This study 
This study 
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2.2 Cell line and culture conditions 
The mouse macrophage cell line J774A.1 (DSMZ No. ACC170) and the human type 
II pneumocyte cell line A549 (ATCC No. CCL185) were maintained and passaged twice 
weekly in DMEM and RPMI 1640 (GibcoTM, Grand Island, NB, USA) respectively. Both 
media were supplemented with 10% fetal bovine serum (Bio Whittaker, Walkersville, MD, 
USA). Cultivation of cells was performed in BD FalconTM 75 cm2 flasks (BD Biosciences) at 
37°C and 5% CO2 (Lewin et al., 2003). 
Murine bone marrow macrophages (BMMs), kindly provided by Stefan Kaulfuss, 
were derived in vitro from bone marrow progenitors of black female C57BL/6 mice as 
described previously (Dorner et al., 2002). Prior to infection BMMs were maintained in D-
MEM supplemented with 10% foetal calf serum (Biochrom AG, Berlin, Germany), 5% horse 
serum (Biochrom AG), 1% 1mM Na-Pyruvate and 1% L-Glutamin. 
Axenic A. castellanii (Walochnik et al., 2000) was grown to 90% confluence at 28°C 
in the dark in BD FalconTM 75 cm2 flasks (BD Biosciences) containing PYG broth (Moffat & 
Tompkins, 1992). 
 
2.3 Molecular biology techniques 
Common molecular biology techniques were carried out according to standard 
protocols (Sambrook et al., 1989) or according to the recommendations of the manufacturers 
of kits and enzymes. Sequencing reactions were performed by using the Prism Big DyeTM FS 
Terminator Cycle Sequencing Ready Reaction Kit from PE Applied Biosystems (Darmstadt, 
Germany). Transformation of E. coli was performed according to the method of Hanahan 
(Hanahan, 1983). 
 
2.4 In silico analysis 
Protein and nucletide sequence analysis was performed using the software packages 
MacVectorTM 7.2.3 (Accelrys, Cambridge, UK) and Lasergene (DNASTAR, Inc., Madison, 
WI, USA). Signal peptides were predicted using the SignalP 3.0 Server at 
http://www.cbs.dtu.dk/services/SignalP/ (Bendtsen et al., 2004).  
Phylogenetic relationships among the RGM were analyzed using the program ClustalW 
in the MacVectorTM 7.2.3 package. Before analyzing the phylogenetic relationships, 
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sequences were trimmed in order to start and finish at the same nucleotide position for all 
employed strains. Phylograms were obtained from nucleotide sequences using the neighbor-
joining method with Kimura 2-Parameter distance correction (Kimura, 1980). 
 
2.5 Isolation of genomic DNA from mycobacteria 
Mycobacteria were grown to an OD600 of 1-1.5. 5 ml of the culture was harvested by 
centrifugation at 6000 × g and 4°C. The pellet was resuspended in 400 µl TE-buffer (pH 8) 
and mycobacteria were inactivated at 80°C for 30 min. After cooling down the samples to 
room temprature, 5 µl of lysozyme (150mg/ml) was added to the suspension and was 
subsequently incubated at 37°C over night. 70 µl of 10% SDS and 5 µl Proteinase K (20 
mg/ml) were added to the lysate. The sample was then incubated for 1 h at 60°C. After 
addition of 100 µl 5M NaCl and 100 µl CTAB the sample was incubated at 65°C for 10 min. 
After an initial chloroform extraction, DNA was purified by phenol/chloroform extraction 
followed by precipitation of DNA by ethanol. The genomic DNA was used for experiments as 
Southern Blots, cloning or was applied as template in PCRs, respectively. 
 
2.6 Protein preparation and Western Blot 
Selective extraction of MspA from M. smegmatis was carried out with the detergent n-
octylpolyoxyethylene (nOPOE) from Bachem (Heidelberg, Germany) according to Heinz and 
Niederweis ( 2000). Isolation of recombinant MspA (rMspA) from M. bovis BCG and porins 
from the M. fortuitum-group was performed in PBS buffer supplemented with 0,5% (w/v) 
nOPOE and 0.2% EDTA (POP05) by slightly modifying the method of Heinz and 
Niederweis. M. bovis BCG was grown to an OD600 of up to 3 and members of the M. 
fortuitum-group were grown to an OD600 of up to 1. Subsequently about 350 mg of M. bovis 
BCG or 150 mg of M. fortuitum-group (wet weight) were washed twice in PBS buffer 
supplemented with 0.2% EDTA. Pellets were resuspended in POP05 using a ratio of 200 µl 
POP05 per 100 mg mycobacteria and were incubated at 100°C for 30 min. Afterwards the cell 
debris was pelleted by centrifugation at 27 000 × g and 4°C, the supernatant was transferred to 
a new tube and quick-freezed in liquid nitrogen. Quantification of protein samples was carried 
out using the BCA Protein Assay Reagent Kit (Pierce, Rockford, IL, USA). 
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Protein samples were mixed with 4x loading buffer (Heinz et al., 2003b), incubated for 
10 min at room temperature, separated by SDS-PAGE (10%) and transferred at 1.2 mA/cm2 
constant current for 50 – 90 min to a PVDF membrane (Bio-Rad Laboratories GmbH, 
München, Germany) in the semidry blotter Trans Blot SD (Bio-Rad Laboratories) using 
Towbin buffer (25 mM Tris, 192 mM glycine and 20% methanol, pH 8.3). The detection of 
porins in immunoblot experiments was carried out with the polyclonal rabbit antiserum pAK 
MspA#813; kindly provided by Dr. M. Niederweis; (Heinz & Niederweis, 2000). Western 
blotting and detection was performed with the BM Chemiluminescence Western Blotting Kit 
(Roche Diagnostics GmbH, Mannheim, Germany) using a 1:4000 dilution of the antiserum.  
 
2.7 M. bovis BCG experiments 
2.7.1 Cloning of mspA in M. bovis BCG 
A 3429 bp fragment including mspA was obtained from genomic DNA of M. 
smegmatis by PCR using the primers mspA2-I 5’-CGA TAT CCC GAC CGT GAC TGG 
CTC AAG-3’ and mspA2-II 5’-GAA GCT TGT CCA TGA CGG AGT TGG CGG-3’ with 
the LA PCR Kit (TaKaRa BIO Europe S.A., Gennevilliers, France). Preliminary sequence 
data was obtained from The Institute for Genomic Research through the website at 
http://www.tigr.org.  The 3429 bp fragment was digested with EcoRV and SmaI and cloned 
into the unique EcoRV site of the plasmid pMV306 (Stover et al., 1991), which is an 
integrative vector carrying the kanamycin resistance gene aph from transposon Tn903, the 
gene for the integrase and the attP site of phage L5. The recombinant plasmid (pSSa100, 
Figure 2) was introduced into M. bovis BCG by electroporation. For electroporation, 
competent M. bovis BCG were pulsed with 1000 Ω, 25 µF, 2.5 kV in 2 mm electroporation 
cuvettes.   
 
2.7.2 RT-PCR with mRNA from M. bovis BCG derivatives 
RNA was extracted from recombinant strains of M. bovis BCG according to the 
method of Bashyam (Bashyam & Tyagi, 1994). 250 ng of the RNA was treated prior to RT-
PCR with RQ1 RNase-Free DNase (Promega GmbH, Mannheim, Germany). Half of the 
treated RNA was added to the RT-PCR reaction carried out with the Access RT-PCR System 
(Promega). The following specific primers were designed to prove the expression of mspA by 
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amplifying a fragment of 228 bp: AT/POR/FW (5’-TGG ACC GCA ACC GTC TTA CC-3’) 
and AT/POR/BW (5’-GGG TGA TGA CCG AGT TCA GGC-3’). The expression of the 
selection marker aph conferring kanamycin resistance was demonstrated by amplifying a 
fragment of 556 bp using the primers Tn903/AS1 (5’-TGA GTG ACG ACT GAA TCC GGT 
GAG A-3’) and Tn903/S1 (5’-CGA GGC CGC GAT TAA ATT CCA AC-3’). A non-
reverse-transcribed PCR control was performed with the same samples to guarantee the 
absence of contaminating genomic DNA. 
 
2.7.3 Growth experiments 
Dilutions of cultures of recombinant strains of M. bovis BCG were grown on 
Middlebrook 7H11 (BD Biosciences) agar plates supplemented with 0.5% glycerol and 
OADC (BD Biosciences) and were incubated at 37°C. Colonies per plate were counted, 
washed from the plate with Middlebrook medium and transferred into a collection tube; 
afterwards the volume was adjusted to 3 ml. The colonies were resuspended by sonicating in 
sealed tubes for 10 seconds at 4°C and 450 W with the Branson Sonifier 450 (Branson 
Ultrasonics Corporation, Danbury, USA). ATP synthesis was chosen as a reference for 
growth of mycobacteria on plates. The ATP concentration of appropriate dilutions of the 
resuspended colonies was quantified by three measurements for each sample using the ATP 
Bioluminescence Assay Kit HS II (Roche) and the microplate luminometer LB96V 
(Microlumat Plus, EG & G Berthold, Bad Wildbad, Germany) according to the 
recommendations of the manufacturer. All ATP values were standardized to relative light 
units (RLU)/100 colonies. 
Determination of growth of recombinant strains of M. bovis BCG in broth was carried 
out in Middlebrook 7H9 medium. Afterwards 120 ml of medium was inoculated with log 
phase M. bovis BCG to an OD600 of 0.02, evenly distributed into three flasks and incubated at 
37°C without shaking. Growth was determined during six weeks by measuring the OD600 of 
cultures and determination of the cellular ATP content using the ATP Bioluminescence Assay 
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2.7.4 In vitro mutagenesis of pSSa100 
Mutants of the recombinant plasmid pSSa100 were obtained by in vitro random 
insertion of a transposon with the EZ::TNTM <TET-1> Insertion Kit (Epicentre, Madison, WI, 
USA) with tetracycline as a marker for selection of mutants. E. coli DH5α was transformed 
with mutagenized DNA and was grown on plates containing tetracycline and kanamycin. 
Extracted plasmid DNA of several clones was sequenced to identify insertion loci and an 
insertion mutant of pSSa100 containing the transposon in mspA (Tn#39, Figure 2) was finally 
introduced into M. bovis BCG by electroporation. 
 
2.7.5 Infection of cells and measurement of intracellular growth 
Infections of the macrophage cell line J774A.1 and the pneumocyte cell line A549 
were performed in 24 well plates (BD Biosciences). 5 × 104 cells of J774A.1 or 7 × 104 cells 
of A549 per well were seeded and allowed to adhere over night. Cells were then infected at a 
multiplicity of infection (MOI) of 10 CFU with M. bovis BCG. J774A.1 was infected for 6 
hours and A549 for 24 hours. Afterwards the supernatants were removed and adherent cells 
were washed twice with PBS buffer. The cells were then treated with 200 µg ml-1 amikacin 
for two hours to kill the unphagocytosed M. bovis BCG. After washing twice with PBS 
buffer, 1 ml medium supplemented with 1 µg ml-1 amikacin was given to each well. Samples 
for quantification of intracellular bacteria were taken at the end of the infection time after 
removal and killing of extracellular bacteria and then daily for four days. 
The intracellular growth was determined by measuring the DNA synthesis of M. bovis 
BCG by Real-time PCR with the ABIPrism 5700 Sequence detection System (PE Applied 
Biosystems). For the extraction of DNA 100 µl of the cell lysate was added to 200 µl Te9 
buffer (Goelz et al., 1985). The mixture was first incubated at 58°C for 60 min and then at 
97°C for 30 min. DNA was extracted with phenol/chloroform, precipitated with ethanol and 
the pellet was resuspended in 25 µl sterile dH2O. The M. bovis BCG DNA was quantified by 
amplifying a fragment of 130 bp from the 85B α antigen using the primers MY85FW/BW 
(5’-TCA GGG GAT GGG GCC TAG-3’ and 5’-GCT TGG GGA TCT GCT GCG TA-3’, 
(Desjardin et al., 1996) and the dually labelled detector probe 5’-(FAM)-TCG AGT GAC 
CCG GCA TGG GAG CGT-3’-(TAMRA) (Hellyer et al., 1999). The reaction was performed 
with the MBI Fermentas PCR Kit (Fermentas GmbH, St. Leon-Roth, Germany) in 50 µl 
reaction mix containing 5 µl of the DNA sample as template, 0.2 mM of each dNTP, 3 mM 
 
 
Materials and Methods 15 
MgCl2, 150 ng of each primer, 184 nM probe, 1 U Taq DNA polymerase, PCR buffer and 
1µM ROX (6-Carboxy-X-rhodamin) as passive reference dye. Amplification was carried out 
by running a first step at 97°C for 5 min followed by 40 cycles with 30 s at 95°C and 1 min at 
63°C. DNA amounts were determined by three measurements for each sample using a 
standard established with known amounts of genomic M. bovis BCG DNA. 
 
2.8 RGM  experiments 
2.8.1 Construction of M. smegmatis deletion mutants and complementation of the 
mutations 
In strain M. smegmatis MN01 (∆mspA) the mspA gene was partially deleted by 
homologous recombination as described by Stahl et al. ( 2001). In strain M. smegmatis ML10 
(∆mspA∆mspC) the mspA and the mspC gene were deleted (Stephan et al., 2004b). Both 
strains were kindly provided by Dr. M. Niederweis. 
The plasmids pSSa100 (Sharbati-Tehrani et al., 2004) and pMN013 (Mailaender et al., 
2004) were used for complementation of porin mutations in the strains MN01 and ML10. As 
mentioned above, pSSa100 is an integrative plasmid harboring mspA including its own 
promoter. pMN013 carries a transcriptional fusion of the promoter pimyc with the mspA gene. 
Plasmids were introduced into M. smegmatis derivatives via electroporation as described 
above. 
 
2.8.2 Growth experiments in broth 
Determination of growth of M. smegmatis strains SMR5, MN01 and ML10 in vitro 
was carried out in Middlebrook 7H9 medium at the pH 5.0 and pH 6.7. Prior to inoculation, 
log phase M. smegmatis were washed twice with PBS supplemented with 0.05% Tween 80 
(PBS-T) to minimize the formation of aggregates. Afterwards 120 ml of medium was 
inoculated with 3 × 107 CFU, evenly distributed into three flasks and incubated at 37°C 
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2.8.3 Infection of macrophages and measurement of intracellular growth 
Infection of the macrophage cell line J774A.1 as well as BMMs was performed as 
described above for M. bovis BCG with the following modifications. 5 × 104 cells/well were 
seeded in 24 well plates (BD Biosciences). J774A.1 were allowed to adhere for two hours and 
BMMs over night. Cells were then infected with log phase M. smegmatis strains at an MOI of 
1 in triplicate. After 4 hours the supernatants were removed and adherent cells were washed 
twice with medium. The cells were then treated with 200 µg ml-1 amikacin for one hour to kill 
the non-phagocytosed M. smegmatis. After washing twice with medium, 1 ml medium 
supplemented with 2 µg ml-1 amikacin was given to each well to prevent extracellular growth. 
Samples for quantification of intracellular bacteria were taken at the end of the infection time 
after removal and killing of extracellular bacteria and then twice per day until 54 hours post 
infection. After removal of supernatants lysis of cells was performed by addition of 1ml 
sterile dH2O and incubation at 37°C until complete lysis. The intracellular persistence of M. 
smegmatis was determined by plating and colony counting. 
 
2.8.4 A. castellanii Infection 
Prior to infection A. castellanii monolayers were washed with A. castellanii buffer 
(Moffat & Tompkins, 1992), were harvested and resuspended in A. castellanii buffer. 105 A. 
castellanii/well were seeded in 24 well plates (BD Biosciences) and allowed to adhere for one 
hour. Afterwards amoebae were infected with log phase M. smegmatis strains at an MOI of 10 
(Cirillo et al., 1997) in triplicate. After an initial infection time of 2 h further treatment was 
performed according to the infection procedure for J774A.1 cells by replacing the medium 
with A. castellanii buffer, except that no amikacin was added to A. castellanii buffer after the 
washing procedure. Intracellular mycobacteria were recovered by lysing the amoebae with 
PBS supplemented with 0.5% SDS (Cirillo et al., 1997). The intracellular persistence of M. 
smegmatis was determined by plating and colony counting. 
At the time point 4 h post infection quantification of DNA of intracellular 
mycobacteria was performed to confirm consistent uptake of different strains by amoebae 
using the Mx3000PTM Real-time PCR System (Stratagene, La Jolla, CA, USA). Extraction of 
DNA was performed as described above. M. smegmatis DNA was quantified by amplifying a 
fragment of 91 bp from the 16S rRNA using the primers myco16STaq FW and BW (5’-AGG 
GTG ACC GGC CAC ACT G-3’ and 5’-ATC AGG CTT GCG CCC ATT GT-3’) and the 
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dually labeled detector probe 5’-FAM-TGA GAT ACG GCC CAG ACT CCT ACG GGA-
TAMRA-3’. The reaction was performed with the MBI Fermentas PCR Kit (Fermentas 
GmbH) in 50 µl reaction mix containing 7 µl of the DNA sample as template, 0.2 mM of each 
dNTP, 3 mM MgCl2, 100 ng of each primer, 60 nM probe, 1 U Taq DNA polymerase, PCR 
buffer and 30 nM ROX as passive reference dye. Amplification was carried out by running a 
first step at 97°C for 5 min followed by 40 cycles with 30 s at 95°C and 1 min at 63°C. DNA 
amounts were determined by three measurements for each sample using a standard 
established with known amounts of genomic M. smegmatis DNA. 
 
2.8.5 Quantification of expression of porin genes by RT-Real-time PCR 
Expression of porin genes in the different strains was determined by means of RT-
Real-time PCR using the Mx3000PTM Real-time PCR System (Stratagene). M. smegmatis 
derivatives were grown to an OD600 of 0.8 and RNA was extracted according to Bashyam and 
Tyagi ( 1994). 1 µg of the RNA was treated prior to RT-Real-time PCR with RQ1 RNase-
Free DNase (Promega GmbH). The expression of porin genes from M. smegmatis and 
memebers of the M. fortuitum-group was quantified by amplifying a fragment of about 100 bp 
using the primers and probes as indicated in Table 3. The reaction was performed with the 
Access RT-PCR System (Promega) in 50 µl reaction mix containing 1 µl (100 ng) of the 
DNase treated RNA as template, 0.2 mM of each dNTP, 1 mM MgSO4, 40 pmol of each 
primer, 50 nM probe, 5 U AMV Reverse Transcriptase, 5 U Tfl DNA Polymerase, AMV/Tfl 
Reaction Buffer and 30 nM ROX as passive reference dye. Amplification was carried out by 
running a first reverse transcription step at 48°C for 45 min followed by 2 min at 94°C and 40 
cycles with 30 s at 94°C and 1 min at 58°C. RNA amounts were determined by three 
measurements for each sample using a calibration curve established with known amounts of 
linearized pSSa100. Non-reverse-transcribed PCR controls were performed with the same 
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Table 3:  Primers and probes used for quantification of porin expression by RT-Real-time PCR.  
Gene Primers and probes Sequence 5’-3’ 
mspA   
 mspATaqFW 5’-CGT GCA GCA GTG GGA CAC CTT-3’ 
 mspATaqBW 5’-CCA CGA TGT ACT TGG CGC GAC-3’ 
 mspATaqProbe 5’-FAM-TGG ACC GCA ACC GTC TTA CCC GTG AGT G-TAMRA-3’ 
porM1   
 mfpqPCRfw 5’-CGT TCA GCA GTG GGA CAC CTT-3’ 
 mfpqPCRrev 5’-CCA CGG TGT ACT TGG CCC GGC-3’ 
 mfpqPCRprobe 5’-FAM-TGG ACC GCA ACC GGC TGA CCC GTG AGT G-TAMRA-3’ 
 
2.8.6 Electron microscopy 
For transmission electron microscopy (TEM) of uninfected and infected A. castellanii, 
the A. castellanii buffer was replaced by glutaraldehyde (2.5%, v/v) buffered with 0.05 M 
Hepes (pH 7.2) and fixed first for 1 h at room temperature, then stored at 4°C in the same 
solution. The cells were first agarose-block embedded by mixing equal volumes of cells and 
low melting point agarose (3% PBS), postfixed with OsO4 for 1 h (1% in ddH2O; Plano, 
Wetzlar, Germany) and block-stained with uranyl acetate for 1 h (2% in ddH2O; Merck, 
Darmstadt, Germany). The samples were then dehydrated stepwise in graded alcohol and 
embedded in LR-White resin (Science Services, Munich, Germany), which was polymerized 
at 60°C over night. Ultra thin sections were prepared with an Ultramicrotome (Ultracut S, 
Leica, Germany) and placed on naked 400-mesh grids.  The sections were stained with lead 
citrate and stabilized with approximately 1.5 nm carbon (carbon evaporation; BAE 250, Bal 
Tec, Liechtenstein). Transmission electron microscopy was performed with an EM 902 
(Zeiss, Oberkochen, Germany) using a slow scan CCD-camera (pro scan, Scheuring, 
Germany). All electron microscopy experiments were performed in collaboration with Dr. M. 
Özel and G. Holland (Robert Koch-Institute, Berlin, Germany). 
 
2.8.7 Detection of porin genes from the M. fortuitum-group by Southern Blotting 
About 1 µg genomic DNA from M. fortuitum strains and M. peregrinum strains was 
isolated as described above and was then digested to completion with the restriction enzyme 
SacII (Cfr42I) and separated by agarose gel electrophoresis. The DNA was then transferred to 
the Hybond+ membrane (Amersham Biosciences, Freiburg, Germany) as described by 
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Sambrook et al. ( 1989). Porin genes were detected using a Flourescein labeled probe of 700 
bp, which was established from M. fortuitum 10860/03 genomic DNA using the primers Mf-
4IV-fw (5’-TCT CCA GGG GCT GCT TTT G-3’) and Mf-4-bw (5’-CGG GAC GCC AAC 
CAC ATA AC-3’) and the PCR Fluorescein Labeling Kit (Roche) according to the 
manufacturers instructions.  
 
2.8.8 Cloning of the porin porM1 from M. fortuitum 10860/03 and its detection in other 
members of the M.fortuitum-group 
Genomic DNA from M. fortuitum 10860/03 was digested with the restriction enzyme 
SacII and separated by agarose gel electrophoresis. The region about 3000 bp was cut out of 
the gel and DNA was eluted using the QIAquick Gel Extraction Kit (Qiagen, Hilden, 
Germany). Afterwards the eluted DNA was ligated into the unique SacII site of the plasmid 
pIV2 (Strauch et al., 2000) and the ligation was transformed into E. coli DH5α. 
Transformants were screened by Dot Blot analysis using the probe mentioned above. Inserts 
of the identified recombinant plasmids pSSp107 and pSSp108, which harbored porin 
sequences, were then sequenced. Identification of orthologus genes from other members of 
the M. fortuitum-group was performed by PCR using the primers KOMF 3F (5’-CTG AAG 
CTT CAC CGA GCT GAG CAT CCT CAC-3’) and KOMF 4B (5’-GAC ACT AGT CGT 
TGG CTA CAG AAC AAC ATT CC-3’) and the Advantage GC 2 PCR Kit (BD 
Biosciences). Both strands of the PCR products were then sequenced. 
 
2.8.9 Detection of porins by 2-D Electrophoresis 
About 75 µg of protein was precipitated by aceton and pellets were washed with 70% 
aceton to desalt the sample. Afterwards pellets were resuspended in 200 µl Rehydration 
solution (8M urea, 0.5% CHAPS, 0.2% DTT, 0.5% Pharmalyte, 0.002% bromphenol blue), 
incubated for 5 h at room temperature and loaded on IPG strips pH 3-5.6 NL, 11 cm 
(Amersham Biosciences). The strips were focused on an Ettan IPGphorII unit and the second 
dimension was run on vertical 10% SDS-PAGE gels using the Ettan Daltsix electrophoresis 
unit (Amersham Biosciences) according to the manufacturers instructions. The gels were 
stained by silver using Roti-Black P (Carl Roth GmbH, Karlsruhe, Germany). Porins were 
detected by Western Blotting as described above.  
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2.8.10 Quantification of porin by ELISA 
In addition to the RT-Real-time PCR experiments the amount of porin in members of 
M. fortuitum-group and M. smegmatis was determined by Enzyme-Linked Immunosorbent 
Assay (ELISA). Protein was isolated from mycobacteria using the detergent nOPOE as 
described above. The protein isolation (15 µl corresponding approximately to 25 µg) was 
diluted in 50 mM NaHCO3, pH 9.6 to yield a protein concentration of about 5 µg/100 µl. 
Aliquots (100 µl) of the sample and dilutions thereof were loaded to wells of a Nunc-Immuno 
Maxisorp Module (Nalge Nunc International, NY, USA). After incubating the samples at 4°C 
overnight, wells were washed twice with TBS-T (50 mM Tris-HCl, pH 7.8, 150 mM NaCl, 1 
mM MgCl2 and 0.05% Tween 80). The surface was blocked with 3% powdered skim milk in 
TBS for 1.5 h at room temperature followed by three steps of washing with TBS-T. Samples 
were then treated with the primary antibody for 1.5 h at room temperature, using a 1:1500 
dilution of the antiserum pAK MspA#813 in TBS. The wells were washed five times with 
TBS-T and were incubated for 1 h at room temperature with a 1:7500 dilution of Peroxidase-
conjugated AffiniPure F (ab’) 2 Fragment Goat Anti-Rabbit IgG (H+L) (Jackson Immuno 
Research, Soham, UK) in TBS. After five steps of washing the reaction was performed using 
the SureBlueTM TMB Microwell Peroxidase Substrate (KPL, Geithersburg, MD, USA) 
according to the instructions of the manufacturer. Absorption at 450 nm was measured with 
the microplate reader SPECTRA Fluor (TECAN, Crailsheim, Germany). 
 
2.8.11 Detection of PorM1 at the surface of mycobacteria by means of flow cytometry 
and quantitative microwell immunoassays 
For flow cytometry experiments 40 ml of mycobacterial culture was harvested at O600 
of 0.8, washed with PBS-T and the pellet was resuspended in 1 ml PBS-T. 50 µl aliquots were 
then incubated for 30 min on ice with a 1:100 dilution of antiserum (MspA#813) in PBS-T. 
Afterwards 1 ml PBS-T was given to each sample, mycobacteria were harvested by 
centrifugation and washed once with PBS-T. Pellets were resuspended in 30 µl of a 1:100 
dilution of the secondary R-Phycoerythrin-conjugated AffiniPure F(ab’) Fragment Donkey 
Anti-Rabbit IgG (H+L) (Jackson Immuno Research) and were incubated on ice for 30 min. 
After addition of 1 ml PBS-T, mycobacteria were harvested by centrifugation and were 
washed once with PBS-T. The pellet was then resuspended in 500 µl of PBS-T supplemented 
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with 2% formaldehyde. Fluorocytometric analysis was carried out using a FACScalibur 
cytometer (BD Biosciences). 
40 ml of mycobacterial culture was harvested at OD600 of 0.8, washed with PBS-T and 
the pellet was resuspended in 1 ml PBS-T. 200 µl aliquots were then incubated for 30 min on 
ice with 1 µl of antiserum (pAK MspA#813); for detection of background no antiserum was 
given to the samples. Afterwards 1 ml PBS-T was given to each sample, mycobacteria were 
harvested by centrifugation and washed once with PBS-T. Pellets were resuspended in 100 µl 
of PBS-T and 1 µl of the secondary Peroxidase-conjugated AffiniPure F (ab’) 2 Fragment 
Goat Anti-Rabbit IgG (H+L) (Jackson Immuno Research) was added to each sample and 
incubated on ice for 30 min. After addition of 1 ml PBS-T, mycobacteria were pelleted by 
centrifugation and were washed once with PBS-T. Pellets were then resuspended in 500 µl of 
PBS-T, and 100 µl of dilutions thereof were transferred to wells of a Nunc-Immuno Polysorp 
Module (Nalge Nunc International). After addition of 100 µl SureBlueTM TMB Microwell 
Peroxidase Substrate (KPL) and stopping the reaction by addition of 50 µl 1M HCl, the 
reaction was detected by the reader SPECTRAFluor (TECAN). 
 
2.9 Construction of the suicide plasmid pSSs003 
An all-purpose suicide plasmid harboring only one resistance gene was designed to 
construct allelic exchange mutants of mycobacteria, in particular M. fortuitum. For this 
purpose the plasmids pMN437 (Kaps et al., 2001) and pMN013 were used. The origin of 
replication for E. coli ColE1 was obtained by digestion of pMN437 with the restriction 
enzymes XbaI and Bsp68I. The hygromycin resistance cassette was amplified from pMN013 
by PCR using primers with overhanging 5’ ends, which introduced the restriction sites Bsp68I 
and BspT1 upstream and XbaI and Bsu15I downstream to the gene (VTlongfw2: 5’-CGG 
TCG CGA TAG GCT TAA GGG TAG CGG GTA GCG GTG GTT TTT TTG TTT GC-3’; 
VTlongbw: 5’-GCG CGT CTA GAG CAT CGA TCG ACT GTC CTC GTT GAT CCT TG-
3’) . The precursor plasmid pVTs001 was obtained after ligation of the mentioned fragments. 
A fragment of the multiple cloning site (MCS) of pMV306 was obtained after digestion with 
KspAI and EcoRV and was cloned into the unique Bsp68I site of pVTs001 to obtain the 
suicide plasmid pSSs003. Afterwards both strands of pSSs003 were sequenced.  
For deletion of porM1 in M. fortuitum 10851/03 parts of the porM1 gene including its 
flanking regions were obtained by PCR using primers with overhanging 5’-ends, which 
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introduced additional restriction sites into the PCR products (Figure 20). PCR products were 
then cloned into the restriction sites HindIII/PstI and XbaI/BcuI to obtain the plasmid 





3.1 Heterologous expression of the porin MspA from M. smegmatis in M. bovis BCG 
affects its in vitro growth and intracellular persistence. 
3.1.1 Introduction of mspA into M. bovis BCG 
The lack of efficient porins like MspA in the cell wall of slow-growing mycobacteria 
like M. bovis BCG motivated me to transfer a genomic region of M. smegmatis comprising 
mspA into M. bovis BCG. A 3429 bp DNA fragment containing mspA was obtained by PCR 
and was cloned in the integrative plasmid pMV306 (see section 2.7.1). The generated 
recombinant plasmid (pSSa100) contained besides mspA three other open reading frames 
(ORFs). Two ORFs were located upstream and one downstream of mspA (Figure 2). A blast 
search (http://www.ncbi.nlm.nih.gov/BLAST/) revealed ORF1 to be highly homologous to a 
TetR-family transcriptional regulator of Streptomyces coelicolor. ORF2 had a low homology 
to a putative oxidase of S. coelicolor. ORF3 located downstream of mspA showed a high 
homology to a putative protein of M. tuberculosis CDC1551. Sequencing of the insert of 
pSSa100 revealed rMspA to contain no amino acid replacements. 
 
Figure 2: Map of the plasmid pSSa100. A 3429 bp fragment containing the porin gene mspA was obtained from 
genomic DNA of M. smegmatis by PCR and cloned into the unique EcoRV site of the plasmid pMV306. The 
arrow indicates the location of a transposon insertion in a mutant derivative (Tn#39) of pSSa100. aph: 
aminoglycoside phosphotransferase; attP: attachment site of phage L5; Erep: origin of replication of pUC 




After introduction of pSSa100 into M. bovis BCG via electroporation I could detect a 
growth advantage of M. bovis BCG (pSSa100) in comparison with the reference M. bovis 
BCG (pMV306). Colonies of M. bovis BCG containing the mspA gene appeared about one or 
two days earlier than the reference (data not shown). By performing PCR with primers 
specific for the aph gene of pMV306 (conferring kananmycin resistance) and for the mspA 
gene, I could show that mspA and aph were stably integrated into the genome of the M. bovis 
BCG transformants and were not lost in the course of the experiments (data not shown). 
 
3.1.2 MspA is expressed in M. bovis BCG containing pSSa100 
To investigate the expression of mspA in the M. bovis BCG derivative, I performed 
RT-PCRs. In addition, the expression of the selection marker aph of pSSa100 was chosen as a 
reference for expression of a gene introduced with the same vector system into M. bovis BCG. 
Total RNA was isolated from cultures of M. bovis BCG (pSSa100) and M. bovis BCG 
(pMV306) and RT-PCRs were performed using specific primers binding to mspA and aph. As 
shown in Figure 3 A, lane 2 and 3, an mspA specific RT-PCR product of 228 bp was only 
obtained by using RNA from M. bovis BCG (pSSa100). In addition a 556 bp fragment 
specific for aph was amplified using RNA preparations of both strains (Figure 3 A, lanes 5 
and 6). These results demonstrate the successful transcription of the recombinant mspA in the 
M. bovis BCG derivative. 
Next it had to be answered, if translation of mspA mRNA in M. bovis BCG occured. 
Therefore, Western Blots with protein isolations from both M. bovis BCG strains and M. 
smegmatis were performed. The selective extraction of MspA from M. smegmatis according 
to the method of Heinz and Niederweis ( 2000) showed on a 10% SDS-PAGE the oligomer of 
MspA (data not shown), which was recognized by the polyclonal rabbit antiserum (pAK 
MspA#813) in Western Blot experiments (Figure 3B, lane 1). However, the selective isolation 
of rMspA with nOPOE from M. bovis BCG was not as effective as the isolation of MspA 
from M. smegmatis. Therefore, the cell mass of M. bovis BCG used for the isolation of 
proteins was increased and about 350 mg of M. bovis BCG (wet weight) was employed. 
Although SDS-PAGE of these extracts did not show a defined band for rMspA even after 
silver staining (data not shown), a clear signal for the oligomeric form of rMspA was detected 
in extracts from the M. bovis BCG derivative with pSSa100 in Western Blot experiments 




(pSSa100). However the amount of rMspA in M. bovis BCG was clearly decreased if 
compared with M. smegmatis. As expected, the reference strain M. bovis BCG (pMV306) 
produced no signal with the MspA antiserum (Figure 3 B, lane 3).  
 
 
Figure 3: Expression analysis of mspA in M. bovis BCG derivatives by RT-PCR and Western Blotting. A. 
Transcription analysis of mspA in M. bovis BCG derivatives by RT-PCR. The successful transcription of the 
recombinant porin in M. bovis BCG (pSSa100) is demonstrated by the band of 228 bp (see lane 2) using specific 
primers for mspA. As a control the transcription of the selection marker aph is demonstrated by amplifying a 
fragment of 556 bp (see lanes 5 and 6). Lane 1, 100 bp DNA ladder; lanes 2-4, RT-PCR with specific primers for 
mspA; lane 2, M. bovis BCG (pSSa100); lane 3, M. bovis BCG (pMV306); lane 4, no template control; lanes 5-7, 
RT-PCR with specific primers for aph; lane 5, M. bovis BCG (pSSa100); lane 6, M. bovis BCG (pMV306); lane 
7, no template control. B. Western Blot analysis of isolated proteins from M. bovis BCG derivatives and M. 
smegmatis. Proteins from M. bovis BCG derivatives and M. smegmatis were isolated using the detergent 
nOPOE. The samples from the M. bovis BCG derivatives and M. smegmatis were separated on a 10% SDS-
PAGE and transferred to a PVDF membrane and MspA was detected with the polyclonal antiserum pAK 
MspA#813. The arrow indicates the location of the oligomeric form of MspA. Lane 1, 14 ng of protein extract 
from M. smegmatis; lane 2, 17 µg of protein extract from M. bovis BCG (pSSa100); lane 3, 17 µg of protein 





3.1.3 M. bovis BCG containing mspA shows an enhanced growth on plate 
To investigate the influence of rMspA on growth of M. bovis BCG in vitro growth 
experiments with M. bovis BCG (pSSa100) and M. bovis BCG (pMV306) were performed in 
Middlebrook broth and on Middlebrook plates. Both strains showed a similar growth rate in 
broth measured over a period of 6 weeks (data not shown). However, if the strains were plated 
on agar, a clearly enhanced growth of the M. bovis BCG derivative with the porin was 
noticed, which became apparent as an earlier appearance of colonies and a faster increase in 
colony size (Figure 4 A and C).  
In order to quantify the growth differences between the two strains, the ATP content 
of colonies washed away from agar plates was measured. The M. bovis BCG derivative with 
rMspA always showed higher ATP amounts per 100 colonies than the reference strain. The 
growth advantage of M. bovis BCG (pSSa100) was reflected as two to four-fold higher 
cellular ATP-contents in different experiments (Figure 4 B and D). Thus, it was shown that 
the 3429 bp fragment from M. smegmatis transferred into M. bovis BCG ameliorated its 






Figure 4: Enhanced growth of the M. bovis BCG derivative with rMspA on solid medium. A. Growth of the 
porin derivative M. bovis BCG (pSSa100) and the reference strain M. bovis BCG (pMV306) on Middlebrook 
agar plates 12 days after plating. B. Representative quantification of growth on plate by measuring the ATP 
content reflected as RLU in the luminescence assays. All values are standardized to 100 colonies. The M. bovis 
BCG derivative with rMspA showed up to four-fold higher cellular ATP concentrations if compared with the 
reference. C. Growth of M. bovis BCG (pSSa100), M. bovis BCG (pMV306) and M. bovis BCG (Tn#39, see 
section 4.1.4) streaked out on a Middlebrook agar plate. Sectors 1-3: Single colonies of M. bovis BCG 
(pSSa100) appeared after an incubation time of 16 days, whereas the reference and mutant strains showed either 
very small or no single colonies on plate. D. Effect of mutagenesis of mspA on growth on plates determined by 
representative quantification of the cellular ATP content. The mspA insertion mutant M. bovis BCG (Tn#39) 
showed comparable ATP concentrations as the reference, which were markedly lower than those of the M. bovis 




3.1.4 Mutagenesis of mspA in pSSa100 reveals impairment of growth 
Further proof that the mspA gene was responsible for the observed growth 
enhancement was adduced by transposon mutagenesis. The recombinant plasmid pSSa100 
was mutagenized by an in vitro random insertion of a transposon with a tetracycline marker. 
A mutant with an insertion located in the coding sequence of mspA (Figure 2, Tn#39) was 
introduced into M. bovis BCG. The effect of the insertion on growth of M. bovis BCG on agar 
plates was measured by quantifying the ATP content of colonies containing the mspA gene 
with and without insertion. As shown in Figure 4 C and 4 D, the mutant strain M. bovis BCG 
(Tn#39) showed cellular ATP concentrations similar to the reference strain M. bovis BCG 
(pMV306), while M. bovis BCG (pSSa100) showed an enhanced growth. Hereby I 
demonstrated that the growth enhancement of M. bovis BCG (pSSa100) was caused by the 
introduced mspA gene. 
 
3.1.5 Intracellular growth of M. bovis BCG containing the mspA gene 
The intracellular growth of M. bovis BCG (pSSa100) and the reference strain was 
investigated by infection of non-activated J774A.1 macrophages and A549 pneumocytes by 
quantification of M. bovis BCG DNA via Real-time PCR. The M. bovis BCG strain with the 
recombinant porin showed in J774A.1 cells an initial growth phase until 56 hours post 
infection pronounced by a rapid increase of DNA (Figure 5 A). Until the end of the 
experiment the amount of intracellular M. bovis BCG (pSSa100) increased slightly. In 
contrast the reference strain showed a delayed growth until 80 hours post infection with 
markedly lower amounts of intracellular bacteria. After 80 hours post infection a decline in 






Figure 5: Representative measurement of intracellular growth of the M. bovis BCG derivative with rMspA and 
the reference strain. The DNA of intracellular bacteria was quantified by Real-time PCR. The closed squares 
demonstrate growth of M. bovis BCG (pSSa100) and the open circles growth of the reference M. bovis BCG 
(pMV306). Each value represents the mean (±SD) of DNA amounts from three independent experiments. A. 
Growth of M. bovis BCG derivatives in non-activated J774A.1. The values at 8 hours represent the amount of 
viable intracellular bacteria post infection. B. Growth of M. bovis BCG derivatives in the pneumocytic cells 
A549. The values at 26 hours represent the amount of viable intracellular bacteria post infection. 
 
In the pneumocytic cells A549 an enhanced growth of intracellular M. bovis BCG 
(pSSa100) could be noticed if compared with the reference until 74 hours post infection 
(Figure 5 B). During the rest of the experiment a decline of intracellular M. bovis BCG 
(pSSa100) was detected. On the other hand the reference strain M. bovis BCG (pMV306) 
showed a very slow increase in bacterial amounts until 74 hours post infection followed by a 




These results indicate that M. bovis BCG containing the mspA gene shows an enhanced 
growth in monocytic and pneumocytic cells if compared with the reference. 
 
3.2 Porins limit the intracellular persistence of M. smegmatis 
To detect the potential impact of porins on survival in eukaryotic cells, I investigated 
the intracellular persistence of the wild type SMR5 and two porin deletion mutant strains of 
M. smegmatis MN01 (∆mspA) and ML10 (∆mspA∆mspC) in different models. MspA and 
mspC were chosen for deletions, since they are the only genes of this type of porin, which are 
expressed in the parental strain. After deletion of mspA, however, the homologous genes are 
expressed in the mutant strains (Dr. M. Niederweis, personal communication). Macrophages 
and amoebae were chosen as model systems to analyze intracellular survival. 
 
3.2.1 Intracellular persistence of M. smegmatis strains in macrophages 
I began by investigating the degradation of M. smegmatis strains in J774A.1. As 
shown in Figure 6, a decrease in the number of intracellular mycobacteria was noticed during 
the course of the experiment. However, the double porin mutant ML10 showed significantly 
enhanced intracellular persistence when compared with the two other strains. After 54 h post 
infection SMR5 and MN01 showed bacterial loads of 2.7% and 3.4% when compared to 
bacterial loads after 6 h, whereas the bacterial load of J774A.1 infected with ML10 at 54 h 
amounted to 12.7%. The infection of BMMs produced more distinct differences between the 
three strains. ML10 exhibited throughout the entire experiment significantly higher CFU after 
plating when compared with the other two strains (Figure 6). After 30 h post infection also 
BMMs infected with MN01 showed significantly higher bacterial loads than BMMs infected 
with SMR5. In BMMs infected with ML10, 18.7% of bacteria remained viable after 54 h as 
compared to the 6 h value. With respect to the other two strains, 16.8% of MN01 and only 






Figure 6: Intracellular persistence of M. smegmatis strains SMR5, MN01 and ML10 in J774A.1 and BMMs. 
Each value represents the mean (± SD) of three independent experiments. The values at 6 h represent the amount 
of viable intracellular M. smegmatis post infection. The double asterisks indicate values that varied significantly 
between ML10 and the other strains and the triple asterisks indicate significant differences among all three 
strains according to the paired Student’s t-test (P<0.001). 
 
3.2.2 Intracellular persistence of M. smegmatis strains in A. castellanii 
A. castellanii was shown to serve as a host for mycobacteria such as M. avium. 
Additionally, M. smegmatis was reported to be killed by A. castellanii within a few days 
(Cirillo et al., 1997). Therefore, also this model was chosen to investigate intracellular 




first 20 h post infection. Afterwards the amount of intracellular ML10 did not decrease 
significantly while other strains showed a decline. While in A. castellanii infected with ML10 
about 28% of bacteria remained intracellular and viable (relative to the 4 h values), MN01 and 
SMR5 showed levels between 5% and 0.66%, respectively (Table 4).  
 
 
Figure 7: A. Intracellular persistence of M. smegmatis strains in A. castellanii. Each value represents the mean 
(± SD) of three independent experiments. The values at 4 h represent the amount of viable intracellular M. 
smegmatis post infection. B. Determination of consistent uptake of mycobacteria after 4 h post infection. DNA 
from intracellular mycobacteria was quantified by Real-time PCR. Columns show the mean (± SD) of three 
independent experiments. 
 
To prove that the enhanced persistence of the mutants was in fact caused by the 
deletion of the porin genes, I performed complementation experiments by transforming the 




DNA fragment from M. smegmatis containing the mspA gene with its own promoter in an 
integrative vector, while plasmid pMN013 (see appendix) carries the mspA gene fused to the 
M. smegmatis promoter pimyc on a shuttle vector. The intracellular persistence of the mutants 
carrying either pSSa100 or pMN013 was tested in A. castellanii, because the differences 
between the mutants were most pronounced in this test system. As shown in Figure 7 A and 
Table 5, complementation of the porin deletion in mutant strains was achieved by introducing 
pMN013 as well as pSSa100. While complementation of porin deletion by pMN013 resulted 
in a higher mspA expression in both mutant strains than in the parental strain, 
complementation by pSSa100 was only partial (Table 5). Transfer of pSSa100 only provides 
one copy of mspA to the recipients and mspA is under control of its own promoter. The shuttle 
plasmid pMN013 is present in several copies in mycobacteria and the promoter pimyc is a 
relatively strong promoter (Kaps et al., 2001).  
 
Table 4: Bacterial load in A. castellanii infected with M. smegmatis strains. Values demonstrate the percentage 
of viable intracellular mycobacteria at 44 h post infection when compared to the 4 h values. 
















RT-Real-time PCR experiments confirmed a much stronger expression of mspA from 
pMN013 compared to pSSa100 (Table 5). Transcription of mspA in the mutants carrying 
pMN013 was about 7 to 10 times stronger than in wild type. Nevertheless, both plasmids 
affected an adaptation towards the phenotype of the wild type SMR5 (Figure 7A). The 
complemented strains with pSSa100 were degraded similar to the wild type up to 20 h post 
infection. However, after this time point, their number remained relatively constant until the 
end of the experiment. MN01 (pMN013) and ML10 (pMN013) were degraded more 




the intracellular persistence of the mutants harboring either pSSa100 or pMN013 confirmed 
that the deletion of the porin genes was responsible for the enhanced persistence of the 
mutants in the amoeba (Figure 7 A).  
 
Table 5: Porin expression in the wild type, deletion mutants and complemented strains. Values represent the 
quantification of porin mRNA measured via RT-Real-time PCR. Data are the means (± SD) of three 
measurements. 
Strains Porin expression 
[pg cDNA / ng RNA] 
% of porin expression 
referring to SMR5 
SMR5 15.76 ± 4.89 100 
MN01 0.36 ± 0.02 2.3 
ML10 0.82 ± 0.17 5.2 
MN01 (pMN013) 144.43 ± 10.89 916.3 
MN01 (pSSa100) 2.90 ± 0.12 18.4 
ML10 (pMN013) 111.38 ± 20.80 706.6 
ML10 (pSSa100) 1.73 ± 0.56 11.0 
 
Although all strains were applied at an MOI of 10, the CFU values of the first samples 
taken 4 h after infection already diverged, which is consistent with a kill off of mycobacteria 
by the amoebae starting directly after phagocytosis. Cirillo et al. ( 1997), for example, 
reported that 30 min after entry of M. smegmatis into A. castellanii the majority of bacteria 
were partially degraded. To ensure that equal numbers of bacteria of all strains had been taken 
up by the amoebae, the DNA of intracellular M. smegmatis after the initial infection time was 
quantified. There was no significant difference in the amount of intracellular DNA of all 
tested strains at 4 h post infection (Figure 7 B).  
So far few studies have been performed, which illustrate the intracellular persistence 
of mycobacteria in A. castellanii particularly with regard to M. smegmatis. Therefore, I also 
examined the infection of A. castellanii with the wild type SMR5, MN01 and ML10 by means 
of transmission electron microscopy of samples taken after 18 h (Figure 8), 30 h (Figure 9) 
and 42 h (data not shown) post infection. Phagosomes were detected containing intact bacteria 
as well as degradation products up to 42 h post infection. Most of the phagosomes contained 




At 18 h post infection the wild type SMR5 showed incipient degradation (see arrowhead in 
Figure 8 B) whereas less detritus was observed in phagosomes containing the porin deletion 
mutants (Figure 8 C and D). However, increased degradation was observed over the course of 
infection (Figure 9 B-D).  
 
 
Figure 8: TEM of cultured A. castellanii 18 h post infection. A. Non-infected control. B. Infected with M. 
smegmatis SMR5 (wild type). C. Infected with M. smegmatis MN01 (∆mspA). D. Infected with M. smegmatis 






Figure 9: TEM of cultured A. castellanii 30 h post infection. A. Non-infected control. B. Infected with M. 
smegmatis SMR5 (wild type). C. Infected with M. smegmatis MN01 (∆mspA). D. Infected with M. smegmatis 
ML10 (∆mspA∆mspC). Arrows indicate M. smegmatis, whereas detritus is indicated by arrowheads. 
 
It should be noted that after 30 h post infection some trophozoites rounded up and 
encystment of A. castellanii was observed. Electron micrographs revealed double-walled 
cysts. M. smegmatis was not only present in phagosomes but also was found to be embedded 






Figure 10: TEM of amoeba cyst including mycobacteria (M. smegmatis MN01) in the cyst-wall as indicated by 
the arrow. 
 
3.2.3 Growth of M. smegmatis strains in broth culture at different pH 
As the double mutant lacking mspA and mspC exhibited an enhanced survival in 
phagocytes, the question arose, if this was caused by an improved resistance to acidic pH 
conditions present in the phagosomes. To answer this question, the growth of SMR5, MN01 
and ML10 were compared in Middlebrook 7H9 medium at pH 6.7 and pH 5.0 over 8 days. 
The double mutant strain ML10 exhibited a decreased growth at pH 6.7 and pH 5.0 across the 
course of the experiment when compared with SMR5 and MN01 (Figure 11). No significant 
differences were noticed between the growth of SMR5 and MN01. The differences in the 







Figure 11: Impact of porin deletions on growth of M. smegmatis under different pH-conditions. The strains were 
grown in Middlebrook 7H9 at pH 6.7 or pH 5.0. Measuring points represent the mean (± SD) of three 
independent cultures. 
 
3.3 Characterization of porins from members of the M. fortuitum-group 
Since the saprophytic bacterium M. smegmatis causes disease only in rare cases (Brown-
Elliott & Wallace, 2002), it is important to investigate the role of porins on virulence in more 
pathogenic members of RGM. Members of the M. fortuitum-group were therefore chosen to 
detect and analyze homologous porins of the mspA class. For this purpose, two different M. 
fortuitum strains (10851/03 & 10860/03) and two M. peregrinum strains (9912/03 & 9926/03) 
were employed, which originally were isolated from human patients and were provided by the 
National Reference Center for Mycobacteria at the Research Center Borstel, Germany. 
Comparative analysis was performed using also the type strain M. fortuitum DSM 46621. In 




between the named strains or species, complete sequences of the 16S rRNA genes were 
determined using the primers, which were approved by Adekambi & Drancourt ( 2004). As 
shown in Figure 14, phylogenetic analysis of the 16S rRNA sequences confirmed the 
taxonomic classification of the employed members of the M. fortuitum-group.  
 
3.3.1 PorM1 is present in different members of the M. fortuitum-group 
TO DETECT PORINS HOMOLOGOUS TO MSPA IN MEMBERS OF THE M. FORTUITUM-GROUP, 
HYBRIDIZATION EXPERIMENTS WERE PERFORMED WITH A PROBE DERIVED FROM 
PRELIMINARY PORIN GENE SEQUENCES OF M. FORTUITUM. PRILIMINARY PORIN GENE 
SEQUENCES FROM M. FORTUITUM WERE OBTAINED BY PERFORMING PCRS UNDER LOW 
STRINGENCY CONDITIONS USING PRIMERS DERIVED FROM THE MSPA SEQUENCE. THE PROBE 
HYBRIDIZED TO THE GENOMIC DNA FROM THE M. FORTUITUM STRAINS AS WELL AS TO THE 
GENOMIC DNA FROM M. PEREGRINUM STRAINS. THUS, HOMOLOGOUS PORINS SEEM TO EXIST 
IN ALL STRAINS. THE PROBE HYBRIDIZED TO TWO FRAGMENTS OF THE SACII-DIGESTED 
GENOMIC DNA OF M. FORTUITUM AND M. PEREGRINUM. HOWEVER THE FRAGMENT SIZES 
DIFFERED AMONG THE MEMBERS OF THE M. FORTUITUM-GROUP (FIGURE 12). HENCE, THE M. 
FORTUITUM AND M. PEREGRINUM GENOMES CONTAIN AT LEAST TWO COPIES OF THE PORIN 
GENE.  
 
Figure 12: Occurrence of porin genes among members of the M. fortuitum-group. Chromosomal DNA of 
different strains was digested with SacII and analyzed by Southern blotting. Lanes: 1, M. peregrinum 9912/03; 2, 




3.3.2 PorM1 genes from members of the M. fortuitum-group are highly homologous to 
mspA 
To clone porins from M. fortuitum, genomic DNA of M. fortuitum 10860/03 was 
digested with SacII and a 3000 bp fragment was cut out of the preparative gel. The DNA was 
ligated into the unique SacII site of pIV2 and transformed into E. coli. After screening the 
transformants by Dot Blot analysis, two clones were identified to contain porin sequences, 
from which the plasmids pSSp107 and pSSp108 were isolated. Both plasmids turned out to 
contain the same genomic region of 2895 bp including one porin gene and were chosen for 
further characterization. The inserts were sequenced by primer walking, whereas both strands 
of the porin genes and their surrounding regions were sequenced twice at least. As shown in 
Figure 13, the insert of the plasmids contained several ORFs, one of which (porM1) was 
homologous to mspA. It contained 636 bp, encoding a protein of 211 amino acids with an N-
terminal signal sequence of 27 amino acids, which was predicted using the SignalP 3.0 Server 
at http://www.cbs.dtu.dk/services/SignalP/ (Bendtsen et al., 2004).  
 
 
Figure 13: Map of the insert of plasmid pSSp107. The insert includes the porM1 gene and three other ORFs. 
Up- and downstream to porM1 various nucleotide signal sequences were detected: -10 signal of a promoter 
(TATGTT), a ribosome binding site (RBS: GGAGA), a signal peptide (SP) of 81 bp and a hairpin structure, 
which could represent a terminator. The binding sites of the primers used for detection of the genomic regions of 
porM1 in other employed strains are indicated as KOMF 4B and KOMF 3F.  
 
A hypothetical –10 region of a promoter and a ribosome binding site (RBS) were 
identified upstream of the coding sequence. Downstream of the ORF a hairpin sequence was 
detected, which could function as a terminator (Figure 13). It has to be noted that the 




sequence. According to the designation of other mycobacterial porin genes and to the 
instructions of EMBL nucleotide sequence database, the gene was named porM1.  
Besides the porin gene two other complete ORFs and a part of another ORF were 
detected. ORF1 was interrupted by one of the SacII sites and showed a high homology to a 
molybdopterin biosynthesis protein of M. tuberculosis CDC 1551 (accession-nr.: AAK 
45260). ORF2 turned out to be a mechanosensitive channel homologous to the gene mscL 
from M. avium subsp. paratuberculosis str. 10 (accession-nr.: NP 959854). ORF3 was 
homologous to the hypothetical protein Rv0990c from M. tuberculosis H37Rv (accession-nr.: 
NP 215505). 
Next it had to be answered, whether porM1 was present in other employed strains. 
Thus, the primers KOMF3F and KOMF4B were chosen to amplify a fragment of 
approximately 1250 bp including the porin gene and flanking regions. PCRs, using a 
polymerase-mix with proofreading activity, revealed the specific fragment to be present in all 
strains. Several PCRs were performed and both strands of the different fragments were 
sequenced. PorM1 was detected in all members of the M. fortuitum-group and the nucleotide 
sequences were submitted to the EMBL nucleotide sequence database (Table 6). The 
nucleotide sequences are given in the section Appendix. The nucleic acid subsequences such 
as the -10 signal of a promoter, the RBS, the signal peptide of 81 bp and the hairpin structure 
were also present and were conserved among all tested strains (data not shown). 
 
Table 6: Nucleotide sequence homology between porM1 from members of the M. fortuitum-group and mspA.  
Species Nucleotide similarity index Accession-nr. to the EMBL nucleotide sequence database 
M. fortuitum DSM 46621 88.2% AJ880097 
M. fortuitum 10851/03 88.4% AJ880098 
M. fortuitum 10860/03 87.4% AJ874299 
M. peregrinum 9912/03 86% AJ880099 
M. peregrinum 9926/03 86.9% AJ880100 
 
As already indicated in Table 6, the nucleotide sequences of the gene porM1 differed 
among members of the M. fortuitum-group. The phylogenetic comparison of the employed 
strains based on their porin sequences showed the closest relationship between the type strain 
M. fortuitum DSM 46621 and M. fortuitum 10851/03, it could, however, not reflect the 






Figure 14: Phylograms of the M. fortuitum-group based on 16S rRNA and porM1 sequences using the neighbor-
joining method with Kimura 2-Parameter distance correction. The branch lengths indicate the evolutionary 
distance relative to the scale. M. smegmatis was used as the outgroup. All M. fortuitum strains are shaded yellow 
and the M. peregrinum strains are shaded orange. A. Phylogenetic tree of 16S rRNA gene sequences of 
employed mycobacteria. B. Phylogenetic tree of porin gene sequences of employed mycobacteria. 
 
The amino acid sequences of PorM1 among the M. fortuitum-group were however 
highly conserved (Figure 15). All M. fortuitum strains possessed 100% identical PorM1 
amino acid sequences, whereas M. peregrinum 9926/03 exhibited only one and M. 
peregrinum 9912/26 only two amino replacements compared to the sequence from M. 
fortuitum. According to studies about typical amino acid replacements by Betts & Russel ( 
2003) all amino acid substitutions were exchanges between amino acids preferred for 
membrane proteins. The aliphatic and hydrophobic amino acid Isoleucine was substituted 








Figure 15: Alignment of PorM1 from members of the M. fortuitum-group and MspA. The start codon ATG and 
the stop codon TGA were chosen according to the sequence of mspA. The cleavage recognition site of the signal 
peptidase was predicted for PorM1 using the SignalP 3.0 Server at http://www.cbs.dtu.dk/services/SignalP/ 
(Bendtsen et al., 2004). The predicted signal peptide cleavage sites corresponded to those from MspA. Identical 






The amino acid sequences of porins from members of the M. fortuitum-group and M. 
smegmatis were also highly conserved. The mature proteins (without signal peptide) 
possessed 97.3% similar and at least 96.2% identical amino acids (Betts & Russel, 2003). 
 
3.3.3 PorM1 is expressed in the members of the M. fortuitum-group 
THE EXPRESSION OF THE PORIN PORM1 AND DETECTION OF THE MATURE OLIGOMERIC PORIN 
WAS EXAMINED BY SDS-PAGE, 2D-ELECTROPHORESIS AND WESTERN BLOTTING. THEREFORE, 
PROTEIN WAS ISOLATED FROM M. FORTUITUM 10860/03 USING THE DETERGENT NOPOE AND 
SEPARATED BY 2D-ELECTROPHORESIS. AS SHOWN IN FIGURE 16 A, ABOUT 50 PROTEINSPOTS 
WERE DETECTED ON THE 2D-GEL. WESTERN BLOT EXPERIMENTS WITH IDENTICAL GELS 
SHOWED ONLY ONE DEFINED SPOT DETECTED BY THE ANTISERUM PAK MSPA#813 (FIGURE 16 
A I). THE PROTEIN HAD AN APPARENT MOLECULAR MASS OF APPROXIMATELY 120 KDA AND 
AN APPARENT ISOELECTRIC POINT (IP) OF ABOUT 4, WHICH CORRESPONDED WELL TO THE 






Figure 16: Detection of PorM1 in members of the M. fortuitum-group. 2D-Electrophoresis and Western Blot 
experiments proved PorM1 to be expressed in the analyzed strains. A. 2D-Electrophoresis of protein isolation  
from the strain M. fortuitum 10860/03 using the detergent nOPOE. The arrow indicates the porin spot as proved 
by Western Blot analysis (see section I). B. Detection of the porin in members of the M. fortuitum-group by 
Western Blotting. 10-30 µg of protein was detected by the antiserum pAK MspA#813. Lanes 1-6: 1, M. 
smegmatis SMR5 (10 µg); 2, M. fortuitum DSM 466211 (30 µg); 3, M. fortuitum 10851/03 (30 µg); 4, M. 
fortuitum 10860/03 (30 µg); 5, M. peregrinum 9912/03 (30 µg); 6, M. peregrinum 9926/03 (30 µg). 
 
Since the oligomeric porin was detected in cell extracts of M. fortuitum 10860/03 
(Figure 16 A), other members were tested for expression of PorM1. The mature oligomeric 
form of the porin was shown in cell extracts of the members of the M. fortuitum-group as well 




extended exposition times also the monomeric form of the porin was detected on Western 
Blots (data not shown). Although equal amounts (30 µg) of the cell extracts from members of 
the M. fortuitum-group were blotted on the PVDF membrane, the signals on the Western 
Blots and thus the amount of PorM1 seemed not to be equal among the tested strains (Figure 
16 B).  
 
3.3.4 Members of the M. fortuitum-group express less porin than M. smegmatis 
The disparate signal intensities on Western Blot experiments among the M. fortuitum-
group gave rise to analyze the expression profile of porM1. For this purpose, cell extracts 
with the detergent nOPOE were employed in ELISA experiments to quantify the amount of 
porin in different strains. Furthermore, the expression of porM1 in the members of M. 
fortuitum-group was determined by means of RT-Real-time PCR using sequence specific 
primers and probe and was compared to porin expression in M. smegmatis.  
Different dilutions of the cell extracts from the various strains were loaded to the wells 
of a microtitre plate and porins were detected by an antiserum raised against MspA (pAK 
MspA#813). Higher amounts than 5 µg per well turned out to be inapplicable due to 
saturation effects and the detection of porin in cell extracts failed at concentrations of about 
0.04 µg per well (Figure 17 A). Therefore, the most eligible working range turned out to be 1 
µg cell extract per well. Indeed, the amount of porin differed in various strains. The highest 
amount of porin was detected in the internal control M. smegmatis SMR5. The type strain M. 
fortuitum DSM 46621 exhibited porin amounts close to M. smegmatis, whereas all of the 
strains, which originally were isolated from human patients showed clearly decreased porin 
amounts (Figure 17 A). I observed with particular interest the amount of porin in M. fortuitum 
10851/03, which was the lowest amount among the analyzed RGM. Since M. bovis BCG does 
not possess homologous porins (Niederweis et al., 1999), extracts of M. bovis BCG were 
employed to detect the background. Figure 17 A demonstrates, that the antibody specifically 





Figure 17: Comparative analysis of porin expression among RGM. Expression of porin was detected by means 
of ELISA and RT-Real-time PCR. Each value represents the mean (±SD) of at least three independent 
experiments. A. Quantification of porin in cell extracts of different mycobacteria using the polyclonal antibody 
pAk MspA#813. B. Quantification of porin transcription in various RGM using specific primers and probes for 
mspA or porM1, respectively. C. Combined illustration of the results from ELISA- and RT-Real-time PCR-
experiments. The left ordinate and the blue columns demonstrate the results from ELISA-experiments using 1 µg 





Comparative expression analysis was also performed by means of RT-Real-time PCR 
using specific primers and probes for porM1 or mspA, respectively. 100 ng of RNA 
preparations from RGM were employed to compare the transcription of the porin genes 
among the strains. As it was already proven by the ELISA-results, the highest porin 
transcription was measured in M. smegmatis. It showed about twice as high transcription rates 
as the highest transcription rate among the M. fortuitum-group, which belonged to the type 
strain M. fortuitum DSM 46621. M. fortuitum 10851/03 exhibited the lowest transcription rate 
among all M. fortuitum strains, whereas the two M. peregrinum strains showed even lower 
amounts of porin mRNA than any other tested strain (Figure 17 B). The combined illustration 
(Figure 17 C) of the amounts of porM1 protein and mRNA isolated from various strains 
demonstrates the clear concordance of transcription rates with translation rates of porin genes 
among the RGM.  
These results show that although the amino acid sequences of porin genes among the 
RGM are highly conserved, the expression profiles of porins differ even among the strains of 
one species. 
 
3.3.5 PorM1 is exposed to the surface of M. fortuitum 
MspA was shown to be accessible on the cell surface of M. smegmatis by using the 
antiserum pAK MspA#813 (Stahl et al., 2001). Since the expression analysis showed a 
decreased amount of porin in members of the M. fortuitum-group, M. fortuitum DSM 46621 
and M. fortuitum 10860/03 (the two strains with the highest porin expression rates) were 
exemplary employed for detection of porins at the surface of intact mycobacteria. I first 
started with detection of porins at the surface of M. fortuitum by means of flow cytometry 
experiments, however no MspA-specific signal was measured compared to the 
autoflourescence of untreated mycobacteria (data not shown). Thus, the detection of the 
primary MspA-specific antibody was performed by using a secondary horseradish peroxidase 
conjugated anti-rabbit IgG in quantitative microwell immunoassays. Every molecule of 
peroxidase catalyzes the oxidation of many molecules of substrate, which results in 
amplification of the signal and in turn in a higher sensitivity of the assay compared to flow 
cytometry experiments. As shown in Figure 18, porins were accessible at the surface of intact 
cells of M. fortuitum and were detected by the porin specific antibody. Significantly higher 




10860/03 compared to the relative backgrounds, which were measured by applying only the 
secondary antibody and measuring its non-specific binding.  
 
Figure 18: Detection of PorM1 at the surface of M. fortuitum using the porin-specific antiserum pAK 
MspA#813 in quantitative microwell immunoassays. Each column represents the mean (±SD) of 8 
measurements. Asterisks indicate significant differences between the samples, which were treated with pAK 
MspA#813 and backgrounds according to the paired Student’s t-test (P<0.001). 
The ratio of detected porin at the surface between the two strains was consistent with 
ratios, which were obtained by analyzing the expression profiles (see above). Because of this 
finding and because M. smegmatis expresses higher levels of porin (Figure 17 C), the density 
of porins in the OM of members of the M. fortuitum-group is probably lower than in the OM 
of M. smegmatis. 
 
3.4 Construction of the suicide plasmid pSSs003 
As a consequence of at least eight Mycobacterium genome-sequencing projects, which 
are at or near completion, plenty of sequence data is provided, which remains to be 
functionally characterized. Identification and characterization of new genes, however, 
requires in many cases the mutagenesis of genes and study of phenotypes of the mutant 
strains. I therefore constructed a suicide plasmid suitable for mutagenesis of any 
mycobacterial gene with known nucleotide sequences. There are few appropriate and 




resistance gene, which was applied to construct pSSs003. This plasmid provides two multiple 
cloning sites for cloning of flanking regions from target genes to enable allelic exchange 
between the target sequence and the hyg gene by homologous recombination. The inserted 
fragments can be checked by the two sequencing primers hygseq_1 (5’-TCG CCT TCA CCT 
TCC TGC-3’) and hygseq_2 (5’-GTA ACA GGG ATT CTT GTG TCA C-3’), which allow 




Figure 19: Construction and map of the suicide plasmid pSSs003. It possesses two multiple cloning sites 
(MCS), which flank the hygromycin resistance gene hyg. The binding sites for sequencing primers to prove the 





Currently the flanking regions of porM1 from M. fortuitum 10851/03 are transferred 
into both multiple cloning sites (Figure 20) and mutagenesis experiments have started. 
Deletion of porM1 in M. fortuitum will provide an option to analyze the role of porins on 
pathogenicity of the species. This plasmid is also currently employed to delete the genes for 
the DNA binding proteins mdp1 in M. bovis BCG and hlp1 in M. smegmatis (data not shown).   
 
 
Figure 20: Cloning of flanking regions of porM1 in pSSs003. Parts of porM1 and its flanking regions were 
obtained by means of PCR using the primer pairs KOMF 3F/3B and KOMF 4F/4B. These primers introduce the 
restriction sites as indicated by the underlined and bold letters, which enable the cloning of the PCR fragments in 
the relative restriction sites of pSSs003. 
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4 Discussion 
The majority of the members of the genus Mycobacterium are opportunistic or even 
non-pathogenic environmental species. Some members of the genus, however, are highly 
successful pathogens like M. tuberculosis, M. leprae and M. ulcerans, which cause severe 
human diseases and are of immense medical importance. M. tuberculosis is the causative 
agent of human tuberculosis and due to the infection with this bacterium three million persons 
are killed annually (Dye et al., 1999). Three characteristics of M. tuberculosis result in its 
successful expansion as a hardy pathogen and are commonly used to describe this bacterium: 
latency, dormancy and persistence. M. tuberculosis is able to persist in various ways. The 
most important way to persist is on the cellular level. It resides intracellularly within 
macrophages, cells that are intended to prevent infections by eradication of pathogens. 
Moreover, M. tuberculosis is able to prevent elimination from the host despite of development 
of cell-mediated immunity. Another nontrivial way of persistence is the slow elimination of 
M. tuberculosis by anti-tuberculosis drugs (Gomez & McKinney, 2004). It is of particular 
interest to understand the mechanisms of persistence of mycobacteria and to understand why 
slow-growing and highly pathogenic mycobacteria are such successful persisters, whereas 
fast-growing and non-pathogenic species are eradicated by phagocytes within few days 
(Barker et al., 1996; Cirillo et al., 1997). 
Being concerned with mycobacteria one question arises, why the highly pathogenic 
species belong to the slow-growers, whereas the non-pathogenic or opportunistic 
mycobacteria are fast-growers and whether slow growth in principle could represent a factor 
of virulence. As already mentioned in the introduction, several hypotheses have been 
discussed during the past years, which itemize probable reasons for the slow growth. Jarlier & 
Nikaido ( 1990) discussed the extremely hydrophobic cell wall of mycobacteria to limit the 
permeability for small hydrophilic molecules and to restrict their growth. The principal 
structure of the mycobacterial cell wall is known to be similar among the members of the 
genus (Paul & Beveridge, 1992). However, the equipment of the OM of fast- and slow-
growing mycobacteria with porins differs (Niederweis, 2003). The major porin MspA from 
M. smegmatis is apparently absent in slow-growing and pathogenic mycobacteria (Niederweis 
et al., 1999). Porins forming water-filled channels in the cell wall permit diffusion of small 
and hydrophilic molecules through the mycobacterial OM and are consequently of importance 
for nutrient supply (Stahl et al., 2001). On the other hand, mycobacterial porins have also 
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been associated with excretion of proteins from the periplasmic space into the environment 
(Wiker, 2001). The intention of this study was to find out if and to which degree the presence 
of different types of porins in the OM of mycobacteria affects their growth characetristics and 
intracellular persistence. 
Heterologous porin expression is an adequate approach to study the importance of the 
cell wall permeability for slow-growing mycobacteria like M. bovis BCG. For this purpose the 
coding sequence of mspA was cloned behind the hsp60 promoter in a shuttle vector. However, 
this construct revealed to be unstable after transformation into M. bovis BCG (data not 
shown). This is in accordance with observations of other authors (Al-Zarouni & Dale, 2002; 
Haeseleer, 1994; Kumar et al., 1998), who demonstrated structural instability of 
transcriptional fusions with the hsp60 promoter in M. bovis BCG. Al-Zarouni & Dale (2002) 
have reported frequent deletions in the hsp60 promoter and the tagged gene. 
Therefore, a 3429 bp DNA fragment from M. smegmatis carrying the porin gene mspA 
with its own promoter as well as three additional ORFs was inserted into the integrative 
vector pMV306 and transformed the recombinant plasmid (pSSa100) into M. bovis BCG. 
Since pMV306 integrates with one copy at the att integration site for phage L5 and does not 
carry a mycobacterial promoter in front of the cloning site, the mspA promoter drives the 
expression of mspA in the transformed M. bovis BCG. The plasmid pSSa100 pointed out to be 
stably maintained in M. bovis BCG. 
The expression of the mspA gene in M. bovis BCG was demonstrated by RT-PCR and 
by Western Blot analysis. Using the polyclonal rabbit antiserum to purified MspA (pAK 
MspA#813) I could illustrate the presence of the oligomeric form of rMspA in protein 
extracts from M. bovis BCG containing pSSa100. However, the amount of rMspA in the M. 
bovis BCG derivative was much lower than in the protein extracts from M. smegmatis. Heinz 
and Niederweis ( 2000) had enriched the oligomeric form of MspA from M. smegmatis by 
preparing detergent extracts using Genapol X-80 or nOPOE and had shown the intact 
oligomeric form of MspA to be detectable by means of Western Blotting using the antiserum 
pAK MspA#813. The selective isolation of rMspA from the cell wall of M. bovis BCG using 
detergents like nOPOE yielded lower amounts as the extraction of MspA from M. smegmatis. 
Similar to these results Lichtinger et al. ( 1999) observed channel forming activity in 
detergent extracts of M. bovis BCG and were also not able to show a defined band of the 
protein on SDS-PAGE. This suggests that the expression of mspA in M. bovis BCG was less 
efficient compared with M. smegmatis. Nevertheless the clear signal on the Western Blots 
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with a protein of an apparent molecular mass of 116 kDa proves the successful expression and 
assembly of rMspA in the M. bovis BCG derivative. Heinz and Niederweis ( 2000) showed 
the molecular mass of the oligomeric form of MspA to be dependant on the electrophoretic 
conditions and to vary between 100 and 115 kDa, which is in good agreement with the results 
in this study (Figure 3 B, lanes 1 and 2).  
Growth of the M. bovis BCG transformant containing pSSa100 on agar plates was 
clearly enhanced as shown by measuring the cellular ATP concentrations. The cellular ATP 
content of the mspA-expressing M. bovis BCG was two to four-fold higher than those of M. 
bovis BCG containing the vector pMV306. This in turn reflects the faster growth of the porin 
expressing M. bovis BCG on plate.  Accuracy of growth measurement by this method requires 
homogenous lysis of the bacteria. This was guaranteed by the use of a lysis buffer, which 
ensured complete lysis. The quantification of the cellular ATP concentration of colonies 
turned out to be a reproducible and convenient method to determine the growth of M. bovis 
BCG on plates and was more precise than observation of the time point of colony appearance 
or measuring of colony size. Mycobacterial colonies in general show variations in colony 
sizes caused by aggregate formation (FENNER, 1951) in cultures. This variation in colony 
size is also visible in Figure 4 C and supports the need for other methods, like measurements 
of cellular ATP contents, for the determination of growth on plates.  
Mutagenesis analysis confirmed the mspA gene to be responsible for the growth 
improvement. This result strongly supports the hypothesis that differences concerning the 
equipment with porins and consequently the permeability of the cell wall for nutrients 
influence the generation time of mycobacteria. These results are also supported by the 
observations of Mailaender et al. ( 2004), who also introduced mspA into M. bovis BCG and 
M. tuberculosis. By using a transcriptional fusion of the coding sequence of mspA into the 
relatively strong promoter pimyc (Kaps et al., 2001), they could show increased cell wall 
permeability of the mspA expressing M. bovis BCG for glucose. They also showed a very 
small but significant growth advantage of the mspA expressing M. bovis BCG in broth.  
At first sight these observations seem to be in contrast to observations of Stahl et al. ( 
2001), who found only a very slight growth retardation of a ∆mspA mutant of M. smegmatis 
compared with the wild type in minimal medium with either 1mM glucose or 1 mM 
glucosamine. It must, however, be taken into consideration that M. smegmatis possesses 
additionally to mspA the three highly homologous genes mspB, mspC and mspD which may 
partially compensate the mspA mutation.  
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Although the presence of rMspA enhanced the growth of M. bovis BCG on plates, the 
mspA expressing M. bovis BCG derivatives were still “slow-growing” and by far not as fast as 
any fast-growing Mycobacterium. The generation time of mycobacteria is determined by 
several concomitant factors (see introduction), one of which according to the results of this 
study is the equipment of the OM with porins and hence, the permeability of the 
mycobacterial cell wall. 
After it was shown that heterologous expression of mspA in M. bovis BCG affects its 
growth in vitro, it was of great interest to find out if and how MspA influenced intracellular 
persistence of the M. bovis BCG derivative. The murine macrophage cell line J774A.1 as well 
as the human alveolar pneumocyte epithelial cell line A549 were chosen for persistence 
experiments. Both cell lines were shown to be efficiently infected by M. tuberculosis (Mehta 
et al., 1996). The prerequisite for measurement of intracellular multiplication is a method 
producing results, which are not biased by extracellular bacteria, and therefore much effort 
was put in establishing and verifying the infection experiments. Preliminary tests were 
performed by infecting both cell lines with a gfp-marked M. bovis BCG strain and observed 
the kinetics of phagocytosis by scanning electron microscopy and confocal laser scanning 
fluorescence microscopy. This permitted identification of the optimal infection time for the 
two cell lines and proof of almost complete absence of extracellular bacteria at this time point. 
Real-time PCR was employed to quantify intracellular M. bovis BCG, because this method is 
more precise and even faster than colony counting. Colony counting is known to be inexact 
due to clumping of mycobacteria, particularly upon growth in macrophages. Furthermore, it 
has been reported that CFU plating underestimates the number of intracellular viable 
mycobacteria (Biketov et al., 2000). As has been discussed in the context of the measurement 
of cellular ATP content for growth measurements, the accuracy of the use of Real-time PCR 
for this purpose also requires complete lysis of the mycobacteria. This was achieved by 
boiling the samples after incubation in the presence of proteinase K and SDS followed by 
phenol/chloroform extraction (Lewin et al., 2003). Quantification of intracellular 
mycobacteria by Real-time PCR bears the risk of including dead bacteria. Studies of Barrera 
et al. ( 1993) have, however, shown that measurement of growth of intracellular M. bovis 
BCG within macrophages during four days by a PCR method yielded results equivalent to 
those obtained by CFU counting or measurement of [3H]uracil incorporation. 
While in the macrophage cell line J774A.1an increase in the number of M. bovis BCG 
expressing rMspA occurred during the entire course of the infection, the number of 
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intracellular bacilli in A549 transiently declined 74 h post infection. There is no evident 
explanation for this difference. Nevertheless, the outcome of the infection experiments clearly 
showed that the transfer of the mspA gene into M. bovis BCG enhanced its survival and 
multiplication in macrophages as well as in pneumocytes. It has been shown that nutrients 
available to the bacteria are limiting during infection (Sassetti & Rubin, 2003). Therefore, a 
feasible explanation for enhanced growth of the M. bovis BCG expressing rMspA may be 
improved nutrient uptake. 
Mediation of enhanced survival in macrophages by a mycobacterial channel forming 
protein has also been described by Raynaud et al. ( 2002), who observed that an ompATb 
deletion mutant of M. tuberculosis was impaired in its growth at low pH and in macrophages. 
The ompATb deletion mutant furthermore was impaired in its ability to grow in normal mice. 
In mice lacking T cells, the mutant grew comparable to the wild type. This correlates with my 
observed positive effect of rMspA on intracellular growth of the M. bovis BCG derivative. 
Although OmpATb and MspA do not show any homology and belong to different classes of 
cell wall pores of mycobacteria, the effect of rMspA and OmpATb in intracellular M. bovis 
BCG and M. tuberculosis correlates. The results of this study and the results from Raynaud et 
al. (2002) indicate that channel forming proteins of mycobacteria may have functions 
important for host-pathogen interactions. For instance, porins have been shown to function as 
binding sites for components of the complement cascade (Achouak et al., 2001), to promote 
adhesion to macrophages (Negm & Pistole, 1999) and invasion of endothelial cells 
(Prasadarao et al., 1996), to influence maturation of dendritic cells (Jeannin et al., 2000) and 
phagosomes (Mosleh et al., 1998), to affect cytokine release (Iovane et al., 1998) and to 
modulate apoptosis (Buommino et al., 1999; Massari et al., 2003).  
After it was shown that the heterologous expression of mspA affects the intracellular 
persistence of M. bovis BCG, the question arose whether or to which degree mspA and other 
homologous porins influence the intracellular persistence of the non-pathogenic and 
saprophytic M. smegmatis. It was reported that an mspA deletion mutant of M. smegmatis was 
impaired in nutrient uptake and also in the diffusion of harmful substances like antibiotics into 
the cell, which resulted in a multidrug resistant phenotype (Stahl et al., 2001; Stephan et al., 
2004a). To investigate the significance of porins from M. smegmatis for intracellular survival 
two porin deletion mutant strains were provided by Dr. M. Niederweis. In M. smegmatis 
MN01 the mspA gene was partially deleted (∆mspA) (Stahl et al., 2001) and in M. smegmatis 
ML10 mspA and mspC were deleted (∆mspA∆mspC) (Stephan et al., 2004b).  
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The viability of the mutants was compared to the parental strain in phagocytic cells. 
Compared with survival of the wild type strain, the mutants showed enhanced survival in 
murine macrophages as well as in A. castellanii. Complementation of the porin deletions 
using two different plasmids, which introduced mspA into the mutants, proved the mutation to 
be responsible for the improved persistence. The improvement of intracellular persistence by 
deletion of porin genes of M. smegmatis was most pronounced when A. castellanii was used 
as test system. Amoebae represent a natural test system to analyze the role of mycobacterial 
porins for persistence under natural conditions, and these experiments therefore reflect the 
impact of mycobacterial porins on intracellular survival under real-life conditions. I observed 
with particular interest the presence of M. smegmatis in the walls of cysts of A. castellanii. So 
far, this is the first proof showing that cysts of amoebae might serve as a niche for survival of 
M. smegmatis. The ability of M. avium to survive within cysts of Acanthamoeba polyphaga 
was previously demonstrated (Steinert et al., 1998). Cysts of amoebae are extremely resistant 
against adverse conditions like heat, dryness, lack of nutrients or presence of biocides 
(Miltner & Bermudez, 2000). The ability of M. smegmatis to survive in cysts might therefore 
be of major importance for its survival in unfavorable environments.  
As the enhanced survival of the porin mutants occurred in all three phagocytic systems 
tested, the question came up, which bactericidal mechanism common to macrophages and 
amoebae was less effective in eliminating the porin mutants compared with the wild type. 
Also the diverging effects of the amount of porins on intracellular persistence of M. bovis 
BCG and M. smegmatis were interesting. While the transfer of the porin MspA into M. bovis 
BCG enhanced its intracellular survival, M. smegmatis showed better intracellular survival 
after deletion of one or two porin genes.  
The cell wall permeability has been shown to influence the susceptibility of 
mycobacteria to host antimicrobial molecules like defensins and lysozyme (Gao et al., 2003). 
Differences in the equipment with porins of highly pathogenic slow-growing mycobacteria 
and the less pathogenic RGM may therefore be one of the factors accounting for their 
divergent intracellular persistence. The acidification of the phagosome similarly takes place in 
both macrophages as well as amoebae (McNeil et al., 1983). In contrast to the members of the 
M. tuberculosis-complex, M. smegmatis cannot prevent the acidification of the phagosome. 
After 5 h, the M. smegmatis containing phagosomes exhibit a pH of 5.2 (Cotter & Hill, 2003). 
It is known that M. tuberculosis produces ammonia and that ammonia inhibits phagosome-
lysosome fusion (Clemens, 1996; Clemens et al., 1995; Gordon et al., 1980), which is one of 
 
Discussion  58 
the strategies of pathogenic mycobacteria to survive inside macrophages. Export of ammonia 
by diffusion through rMspA may neutralize the acidification of the phagosome and thus 
enhance the intracellular growth of M. bovis BCG. 
The enhanced intracellular survival of the M. smegmatis mutants is not caused by a 
higher resistance towards low phagosomal pH, because the differences in the growth rates 
between the three strains in broth cultures were not dependent on the pH of the medium. 
However, M. smegmatis is not able to prevent the phagosome maturation and consequently it 
is exposed to the entire mechanisms of host defense. Such bactericidal mechanisms of 
phagocytic cells consist in the production of reactive oxygen intermediates, reactive nitrogen 
intermediates and the activity of antimicrobial peptides and lysosomal enzymes. Reactive 
oxygen intermediates, lysosomal enzymes and antimicrobial peptides are employed by both 
macrophages and amoebae for the degradation of intracellular bacteria (Brooks & Schneider, 
1985; Bruhn et al., 2003). A reduced permeability of the cell wall of the porin mutants for 
small hydrophilic molecules may implicate lower accessibility of anti-microbial substances 
and, as a consequence, better survival of the mutants compared with the parental strain. 
In addition to the diffusion of molecules directly through the porin channels, the 
possibility of altered diffusion rates of molecules through the mycolic acid layer must also be 
considered. Stephan et al. ( 2004a) observed an increase in resistance of the ∆mspA mutant to 
hydrophobic antibiotics. They proposed that the integration of porins in the OM might reduce 
the strong interactions of the mycolic acids and thereby facilitate the diffusion of hydrophobic 
molecules. A reduced diffusion of harmful hydrophobic substances present in the 
phagolysosome of phagocytic cells through the mycolic acid layer of the ∆mspA and the 
∆mspA∆mspC mutants may therefore also contribute to their improved intracellular 
persistence. 
Taken together, these data suggest that intracellular persistence of mycobacteria 
depends, inter alia, on the balance between walling-off towards the hostile environment and 
the uptake of required compounds in the nutrient-depleted phagosomal environment. 
Different views have been expressed among scientists, whether M. smegmatis could 
serve as an appropriate model to study aspects related to virulence of highly pathogenic 
mycobacteria. A notable number of M. tuberculosis genes, which are related to virulence but 
also play a housekeeping role share closely related homologues in M. smegmatis.  In the case 
of common mycobacterial genes M. smegmatis was suggested as an appropriate model 
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organism (Reyrat & Kahn, 2001; Tyagi & Sharma, 2002). On the other hand, the 
physiological differences between M. smegmatis and M. tuberculosis were mentioned to do 
not allow direct comparisons (Barry, 2001). Mutagenesis of porin genes in M. smegmatis 
allows investigating the impact of cell wall permeability on persistence. However, more 
appropriate species for these studies must naturally be able to persist on the cellular level and 
additionally possess a known class of porins, conditions that are fulfilled by M. fortuitum. 
This species is able to infect and grow in phagocytic cells (Sharbati-Tehrani, S., Tykiel, V., 
Appel, B., and Lewin, A., unpublished data) as well as possesses mspA homologues.  
The results of this study show that different strains of M. fortuitum – including the 
type strain – as well as two strains of the non-pathogenic and closely related M. peregrinum 
feature at least two copies of homologous porins of the MspA class. After cloning one of the 
two genes, porM1 was shown to be present in all of the tested members of the M. fortuitum-
group. The amino acid sequences of PorM1 among the species and strains are highly 
conserved, whereas the nucleotide sequences vary. Sequences of bacterial porins can show 
large variations but mature proteins have still the same structure (Niederweis, 2003). PorM1 
has the same apparent molecular mass as MspA, the antiserum raised against MspA binds 
well to PorM1, it is accessible at the surface of M. fortuitum and the mature protein (without 
signal peptide) exhibit only six or seven amino acid replacement, respectively if compared to 
MspA. These features imply very similar functions and characteristics of the two porins. Few 
studies are performed to enlighten the virulence mechanisms of pathogenic RGM like M. 
fortuitum. The investigation on the role of porins on persistence of M. fortuitum would not 
only contribute to the understanding of mycobacterial persistence but also elucidate the 
virulence mechanisms of this poorly investigated pathogen. 
An interesting finding of this study was that the expression of porM1 both at the 
transcriptional level and at the translational level differed among the tested species and 
strains. At the same time the porin expression in the members of the M. fortuitum-group was 
significantly lower than those in M. smegmatis. The differences in porin expression can be 
associated with different abilities of the strains to persist, which remain to be investigated. It 
was shown that M. smegmatis possesses 1000 MspA-like pores per µm2 cell wall (Engelhardt 
et al., 2002). Since the analyzed strains showed clearly decreased porM1 expression both at 
the transcriptional level and at the translational level, the amount of pores in the cell wall of 
M. fortuitum and M. peregrinum has to be distinctly lower than 1000 pores per µm2 cell wall.  
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An interesting result from the various genome-sequencing projects is the different 
genome size between the RGM and the pathogenic slow-growing mycobacteria. Highly 
pathogenic species like M. tuberculosis or M. leprae have genome sizes of about 4.4 Mb and 
3.27 Mb, respectively. On the other hand, M. smegmatis has a genome size of about 7 Mb, 
which is similar to that of the related actinomycete Streptomyces coelicolor. Brosch et al. ( 
2001) reviewed that different data such as 16S rRNA sequences or genome sizes suggest that 
the branch of slow-growing mycobacteria represents the most recently evolved part of the 
genus. They proposed that the loss of genes, rather than gain of genetic material by horizontal 
transfer contributed to the pathogenicity of slow-growing mycobacteria or to the fine-tuning 
of their virulence, respectively. Loss of efficient porins of the MspA class or a decreased 
density of porins in the cell wall play an important role to wall-off towards the hostile 
phagosomal environment and thus of particular importance to become an successful 
intracellular pathogen.  
These data suggest that decreased amount of porins in the cell wall of M. fortuitum may 
represent an evolutionary intermediate stage between saprophytic mycobacteria like M. 
smegmatis and the highly pathogenic slow-growing mycobacteria.  
 Ongoing deletion experiments of porM1 in M. fortuitum 10851/03, which natively 
shows the lowest porin expression levels among the analyzed strains of M. fortuitum, will 
provide an appropriate model to elucidate the role of mycobacterial porins on virulence. 
Future studies on mycobacterial porins will contribute to our understanding of pathogenicity 







The genus Mycobacterium comprises highly pathogenic as well as opportunistic or 
apathogenic species exhibiting a great variability with respect to their growth rates but also 
their ability to persist or multiply on the cellular level. Intracellular persistence is a key 
feature of virulence of M. tuberculosis, the causative agent of human tuberculosis. The 
intention of this work was to find out whether or to which degree the permeability of the 
mycobacterial outer membrane affects the intracellular persistence. For this purpose the major 
porin of M. smegmatis (mspA), which is lacking in slow-growing mycobacteria, was 
expressed in M. bovis BCG. Quantification of bacterial growth on agar plates demonstrated 
clearly increased growth of the M. bovis BCG derivative expressing MspA. Transposon 
mutagenesis proved the mspA gene to be responsible for the growth enhancement. 
Intracellular multiplication of the M. bovis BCG derivative in the mouse macrophage cell line 
J774A.1 and the human pneumocyte cell line A549 was also clearly enhanced. 
 In contrast to this finding, deletion of mspA in M. smegmatis increased its intracellular 
persistence in A. castellanii and murine bone marrow macrophages. Deletion of mspA 
together with another homologous porin mspC in another mutant strain of M. smegmatis 
resulted in decreased growth in broth culture while it significantly enhanced intracellular 
persistence in murine bone marrow macrophages, the mouse macrophage cell line J774A.1 
and A. castellanii, respectively. Complementation of deletions by expression of mspA in the 
porin mutant strains resulted in restoration of the wild type phenotype with respect to 
intracellular persistence.  
These data show that the permeability of the mycobacterial cell wall affects the 
intracellular persistence. These findings also suggest that intracellular persistence of 
mycobacteria depends, inter alia, on the balance between walling-off towards the hostile 
environment and the uptake of required compounds in the nutrient-depleted phagosomal 
environment.  
Furthermore, the gene porM1 encoding a porin homologous to MspA was 
characterized in M. fortuitum. PorM1 was present in different strains of M. fortuitum and in 
the closely related non-pathogenic M. peregrinum. Analysis of expression patterns of porM1 
showed divergent expression profiles among the members of the M. fortuitum-group. Due to 










Die Gattung Mycobacterium beherbergt sowohl hoch pathogene als auch 
opportunistische oder apathogene Arten, die unterschiedliche Wachstumsraten aufweisen und 
außerdem sich in der Fähigkeit intrazellulär zu persistieren unterscheiden. Ein Hauptmerkmal 
der Virulenz von M. tuberculosis, dem Erreger der Tuberkulose im Menschen, ist die 
intrazelluläre Persistenz. Das Ziel dieser Arbeit war herauszufinden, ob und inwiefern die 
Permeabilität der äußeren Membran von Mykobakterien die intrazelluläre Persistenz 
beeinflusst. Hierfür wurde das Porin MspA von M. smegmatis, welches in langsam 
wachsenden Mykobakterien nicht vorkommt, in M. bovis BCG expremiert.  Die 
Quantifizierung des bakteriellen Wachstums auf Agarplatten zeigte einen deutlichen 
Wachstumsvorteil des M. bovis BCG Derivats, das mspA enthielt. Die Mutagenese von mspA 
mittels einer Transposon-Insertion zeigte, dass MspA den veränderten Phänotyp bedingte. 
Des Weiteren zeigte das M. bovis BCG Derivat mit MspA eine verbesserte intrazelluläre 
Persistenz in der murinen Makrophagen-Zelllinie J774A.1 und der humanen Lungenepithel-
Zelllinie A549. 
Im Gegensatz zu diesen Ergebnissen führte die Deletion von mspA in M. smegmatis zu 
einer verbesserten intrazellulären Persistenz in A. castellanii und in murinen 
Knochenmarksmakrophagen. Die Deletion von mspA und dem homologen Poringen mspC in 
einem anderen Mutantenstamm von M. smegmatis führte zu langsamerem Wachstum in 
Flüssigkultur und verbesserter intrazellulärer Persistenz in der murinen Makrophagen-
Zelllinie J774A.1, in A. castellanii und in murinen Knochenmarksmakrophagen. Die 
Komplementation der Mutation durch die Expression von mspA in den Mutantenstämmen 
führte zur Wiederherstellung des Wildtyp-Phänotyps.  
Diese Ergebnisse zeigen, dass die Permeabilität der mykobakteriellen Zellwand die 
intrazelluläre Persistenz und die Wachstumsrate beeinflusst. Außerdem deuten diese Daten 
daraufhin, dass die Persistenz von Mykobakterien abhängig ist von der Balance zwischen der 
Abschottung gegenüber des feindlichen phagosomalen Milieus und der Aufnahme von 
benötigten Nährstoffen in dieser nährstoffarmen Umgebung.  
Weiterhin wurde das Gen porM1von M. fortuitum charakterisiert, das ein homologes 
Porin zu MspA kodiert. PorM1 konnte in allen untersuchten Stämmen von M. fortuitum und 
in zwei Stämmen der nahe verwandten und apathogenen Art M. peregrinum nachgewiesen 




innerhalb der untersuchten Stämme der M. fortuitum-Gruppe. Aufgrund der Fähigkeit von M. 
fortuitum intrazellulär persistieren zu können und aufgrund des Vorhandenseins von Porinen 
wie PorM1, stellt diese Art ein geeignetes Modell dar, um den Einfluss mykobakterieller 
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Table 7: List of abbreviations. 
AG Arabinogalactan 
aph Gene for aminotransferase 
ATP Adenosintriphosphate 
att Attachment site 
BCG Bacille Calmette-Guerin 
bp Basepare 




dH2O Distilled H2O 
DNA Desoxiribonucleic acid 
dNTP Desoxiribonucleoside triphosphate 
ELISA Enzyme linked immunosorbant assay 
EMBL 
European Molecular Biology 
Laboratory 
FAM 6-Carboxyl-Flourecein 
g Acceleration of gravity 
h Hour 
hsp60 Heat shock protein 60 
HYG Hygromycin 
Ig Immunoglobulin 
IM Inner membrane 
int Gene for integrase 





LB Luria Bertani medium 
MA Mycolic acid 
Mb Mega basepare 
min Minute 
MOI Multiplicity of infection 
mspA Mycobacterium smegmatis porin A 
MW Molecular weight 
NCBI 




OD Optical density 
OM  Outer embrane 
ompATb Outer membrane protein A Tuberculosis
ORF Open reading frame 
PBS Phsphate buffered saline 
PCR Polymerase chain reaction 
PG Peptidoglycan 
porM1 Porin Mycobacterium 1 
RGM Rapidly growing mycobacteria 
rMspA Recombinant MspA 
RNA Ribonucleic acid 
ROX 6-Carboxy-X-rhodamine 
rpm Rounds per minute 
rRNA Ribosomal RNA 
RT Reverse transcriptase 
s Second 
SD Standard deviation 
SDS Sodium dodecyl sulfate 
TAMRA Tetramethylrhodamine 
TEM Transmission electron microscopy 
U Unit 




8.2 Maps of plasmids 
 
 
























Figure 25: Plasmid pSSa100, prepared in this work (Sharbati-Tehrani et al., 2004). 
 
 






Figure 27: Mycobacterial suicide plasmid pSSs003, constructed in this work. 
 




8.3 Nucleotide sequences 
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